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Summary 
 
Candida albicans (Ca), an important human fungal pathogen, especially for 
immunocompromised patients, shows several distinct growth morphologies including yeast, 
pseudohyphal or true hyphae forms. Filamentation is considered a major virulence trait, 
since morphological transition from yeast to hyphae has been associated with Ca virulence. 
Various environmental or host stimuli can induce filamentous growth. For instance, 
treatment of Ca with genotoxic agents or depletion of components involved in the DNA 
damage response can trigger pseudohyphal growth. In the yeast Saccharomyces 
cerevisiae, the histone acetyltransferases Hat1, which forms a complex with the subunit 
Hat2, and Rtt109, which also interacts with Asf1, are implicated in DNA damage repair. We 
therefore analyzed the function of Hat1/Hat2 and Rtt109 in Ca. To investigate the function 
of CaHat1 and CaHat2, rabbit polyclonal antibodies were raised. The C-terminal region of 
Hat1 and Hat2, respectively, were expressed as soluble GST-fusion proteins, purified and 
used as antigens.  
Moreover, to investigate the subcellular localization of Hat2, a YFP-tagged Hat2 fusion 
protein was constructed and integrated into the Ca genome. The functionality of Hat2-YFP 
was verified by testing the sensitivity to DNA-damaging agents. In the presence of Hat1, 
Hat2-YFP was mainly localized in the nucleus, whereas in a hat1∆/∆ background the 
nuclear localization was lost. Treatment with DNA-damaging agent MMS led to an increase 
of the signal intensity in the nucleus. 
Homozygous deletion of RTT109 resulted in a hyperfilamentation phenotype, similar to 
what has been observed for hat1∆/∆ as well as hat2∆/∆ strains. rtt109∆/∆ cells showed 
wrinkled colony morphology and pseudohyphal growth under yeast-promoting conditions. 
Furthermore, they were hypersensitive to DNA damaging agents. 
A homozygous asf1∆/∆ strain could not be obtained, suggesting that ASF1 is essential in 
Ca. Placing ASF1 under a conditional promoter was successful for the first allele, but the 
second allele could not be deleted. 
Furthermore, various histone H4 mutants were constructed to study the effect of lysine 
acetylation. Mutations of lysine residues should mimic the acetylated or unacetylated state 
of Hat1 target residues. For this purpose, all but one histone H4 copies were deleted and 
the mutated H4 variant was integrated. A histone H4 variant mimicking the acetylated state 
of H4 was also introduced into the hat1∆/∆ strain to see, if the hat1∆/∆ phenotype could be 
rescued. Even when the acetylated state of both Hat1 acetylation sites was mimicked, cells 
still showed the hat1∆/∆ phenotype of hypersensitivity to DNA damaging agents and 
filamentous growth. 
 

  
Zusammenfassung 
 
Candida albicans (Ca), der häufigste human-pathogene Pilz, besonders bei 
immungeschwächte Patienten, zeigt mehrere unterschiedliche Wachstumsmorphologien, 
wie Hefe, Pseudohyphen und echte Hyphen. Filamentierung gilt als wichtiges 
Virulenzmerkmal, da der Wechsel zwischen Hefe- und Hyphenform mit Virulenz assoziiert 
ist. Verschiedene Umwelt- oder Wirtsstimuli können filamentöses Wachstum induzieren. 
Wachstum als Pseudohyphen kann zum Beispiel durch Behandlung mit genotoxischen 
Substanzen oder Depletion von Komponenten, die in die Antwort auf DNA-Schäden 
involviert sind, ausgelöst werden. In der Hefe Saccharomyces cerevisiae sind die 
Histonacetyltransferasen Hat1, die mit der Untereinheit Hat2 einen Komplex bildet, und 
Rtt109, die mit Asf1 interagiert, in die Reparatur von DNA-Schäden involviert. Daher haben 
wir die Rolle von Hat1/Hat2 und Rtt109 in Ca analysiert. Um die Funktion von CaHat1 und 
CaHat2 zu untersuchen wurden polyklonale Antikörper in Kaninchen produziert. Die  
C-terminale Region von Hat1 bzw. Hat2 wurde als lösliches GST-Fusionsprotein 
expremiert, aufgereinigt und als Antigen verwendet. 
Weiters, um die subzelluläre Lokalisierung von Hat2 zu untersuchen, wurde ein YFP-
markiertes Hat2 Fusionsprotein konstruiert und in das Candida albicans Genom integriert. 
Durch Testen der Sensitivität auf DNA-schädigende Substanzen wurde die Funktionalität 
von Hat2-YFP verifiziert. In der Anwesenheit von Hat1 ist Hat2-YFP hauptsächlich im Kern 
lokalisiert, wohingegen die Kernlokalisierung in einem hat1∆/∆ Hintergrund verloren geht. 
Behandlung mit der DNA-schädigenden Substanz Methylmethansulfonat führte zu einer 
Steigerung der Signalintensität im Kern. 
Deletion von RTT109 führte zu Hyperfilamentierung, ähnlich zu dem, was schon in hat1∆/∆ 
und hat2∆/∆ Stämmen beobachtet wurde. rtt109∆/∆ Zellen zeigten eine runzelige 
Koloniemorphologie und wuchsen als Pseudohyphen unter Bedingungen, die die Hefeform 
begünstigen. Außerdem waren sie hypersensitiv auf DNA-schädigende Substanzen. 
Es war uns nicht möglich einen asf1∆/∆ Stamm zu produzieren. Daher ist anzunehmen, 
dass ASF1 in Ca essentiell ist. Ein Allel von ASF1 konnte unter einen konditionellen 
Promotor gestellt werden, allerdings war es nicht möglich das zweite Allel zu deletieren. 
Weiters wurden einige Histone H4 Mutanten konstruiert. Mutationen von Lysinen sollten die 
acetylierte oder unacetylierte Form von Hat1 Substraten nachahmen. Dazu wurden alle bis 
auf eine Kopie von Histon H4 deletiert und eine mutierte H4 Variante integriert. Eine Histon 
H4 Variante, die die acetylierte Form von H4 nachahmt, wurde auch in den hat1∆/∆ Stamm 
integriert, um zu sehen, ob der hat1∆/∆ Phänotyp wieder umgekehrt werden kann. Leider 
zeigten die Zellen, auch wenn die acetylierte Form von beiden Hat1 Acetylierungsstellen 
nachgeahmt wurde, weiter den hat1∆/∆ Phänotyp von Hypersensitivität auf DNA-
schädigende Substanzen und filamentöses Wachstum. 
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1. Introduction 
1.1. Candida albicans 
 
Several Candida species are normally harmless commensal colonizers of most human 
mucosal layers. They exist as colonizers as part of the microbiological flora in the 
gastrointestinal tract, the genitourinary tract and to a lesser extent on the skin. They can 
cause superficial, non-life threatening infections at these sites. About 75% of women suffer 
from vaginal infections caused by Candida species at least once in their life. In 85 to 90% 
the causative agent for those infections is Candida albicans (Fidel, 2007). Furthermore, 
depending on the immune status of the host, Candida can invade and colonize host tissue. 
Thus, in immunocompromised patients, for example due to cancer chemotherapy, HIV 
infection or immunosuppression after organ transplantation, Candida can also cause 
systemic infections.  
There are over 200 Candida species but only few of them are of medical importance. 
Interestingly, 90% of invasive infections due to Candida species are attributed to C. 
albicans, C. glabrata, C. parapsilosis, C. tropicalis and C. krusei (Pfaller and Diekema, 
2007). Furthermore, Candida species are the fourth-most common cause for nosocomial 
blood-stream infections in the United States with a mortality rate of 40% (Pfaller and 
Diekema, 2007). With the increased prevalence of immunosuppressive therapies and the 
use of broad-spectrum antibiotics incidences of infection have risen (Pfaller and Diekema, 
2004). 
The most frequent causative agent for candidasis is Candida albicans. It is rarely isolated 
from the environment and is therefore considered to be obligatorily associated with 
mammalian hosts. Although C. albicans is a diploid organism without a known haplophase, 
mating has been observed (Hull et al., 2000; Magee and Magee, 2000). It is regulated by 
transcription factors encoded at the mating type locus (MTL). Only cells homozygous at the 
MTL are able to undergo phenotypic switching from white to opaque cells which are the 
mating competent form of C. albicans. After mating the resulting cells can remain tetraploid 
or return to the diploid state by non-meiotic chromosome loss (Bennett and Johnson, 2003).  
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1.1.1. Morphology of Candida albicans 
Candida albicans can grow in three distinct morphological forms: yeast, pseudohyphae and 
true hyphae (Figure 1). Yeast form cells are ellipsoid and appear similar to Saccharomyces 
cerevisiae cells. They divide by budding and separate easily from each other (Berman and 
Sudbery, 2002). True hyphae have parallel sides along their entire length and no 
constrictions between cells. The shape of pseudohyphae can vary enormously, ranging 
from cells resembling yeast cells with elongated buds to cells with the length of hyphae. 
Pseudohyphal cells remain attached to each other after completion of the cell cycle. The 
cells cycle in a unipolar pattern of budding and therefore grow in a highly branched pattern. 
Pseudohyphae have a width greater than the one of true hyphae and have constrictions at 
every septal junction (Sudbery et al., 2004).  
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Figure 1: The three distinct morphological forms of Candida albicans. (A) Cell cycle of the 
yeast form and the first cell cycle of hyphae and pseudohyphae induced from unbudded yeast cells. 
(B) Pseudohyphae form a highly branched structure while the branching pattern of true hyphae is 
less regular. Adapted from Sudbery et al., 2004. 
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Switching from one growth form to another can be induced by several environmental 
stimuli. A range of conditions that more or less mimic certain host conditions like serum, 
neutral pH, hypoxia, higher temperature, certain amino acids and sugars, like N-
acetylglucosamine (GlcNAc), or some synthetic growth media can trigger filamentous 
growth (Ernst, 2000; Shepherd et al., 1980). Furthermore filamentous growth can be 
induced by perturbations of cell-cycle progression. For example, treatment with the DNA-
replication inhibitor hydroxyurea causes filamentous growth (Bachewich et al., 2005; Shi et 
al., 2007). In addition, UV-radiation and the DNA-alkylating agent methyl methane sulfonate 
(MMS) have a similar effect. Thus, DNA replication stress, as well as DNA damage causes 
Candida albicans to switch to filamentous growth.  
 
Figure 2: Several signaling pathways regulate the yeast-hyphae transition. Adapted from 
Berman and Sudbery, 2002. 
 
Many positive and negative regulators of filamentous growth have been identified by now. 
Signals are transmitted by several conserved signaling pathways (Figure 2). A very 
important role plays the cAMP-PKA pathway, which includes the adenylate cyclase Cyr1, 
cAMP-dependent protein kinases Tpk1 and Tpk2 and the transcription factor Efg1. Cells 
with defects in this pathway fail to grow in the hyphal form. Negative regulators of 
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filamentous growth include Tup1, Rfg1, Nrg1 and Rbf1. Deletion of these repressors leads 
to constitutive filamentous growth even under yeast promoting conditions (Biswas et al., 
2007; Liu, 2001). Other pathways regulating filamentous growth include the mitogen-
acitvated protein kinase (MAPK) pathway, the Rim101 pathway induced by alkaline pH, and 
the HOG MAPK pathway, in response to osmostress (Biswas et al., 2007; Liu, 2001). 
The ability of Candida albicans to switch between different growth forms seems to be 
important for pathogenicity. Notably, cells that are locked in either yeast or the hyphal 
growth form show decreased virulence (Gow et al., 2002; Sudbery et al., 2004). 
 
Figure 3: Candida albicans chlamydospores. Adapted from Staib and Morschhauser, 2007. 
 
Chlamydospores are another growth form of Candida albicans (Figure 3). They are thick-
walled, round cells that form at the end of branched filaments or suspensor cells in 
environments that are hypoxic, varying temperature and nutrients (Berman and Sudbery, 
2002; Whiteway and Bachewich, 2007). The biological function of these chlamydospores is 
unknown, although they have been proposed to allow survival in harsh environments. The 
ability to form chlamydospores has served as an important diagnostic tool for the 
identification of Candida albicans for a long time (Staib and Morschhauser, 2007; Whiteway 
and Bachewich, 2007).  
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1.2. Chromatin 
 
In eukaryotic cells, DNA is packaged and condensed into the nucleus in the form of 
chromatin. The basic unit of chromatin is the nucleosome. It consists of 147 base pairs (bp) 
of DNA wrapped 1.7 times around an octamer complex of histone proteins containing two 
copies of each of the four core histones (Figure 4 (A)). Two histone H3 and histone H4 
proteins form a heterotetramer. Together with two heterodimers of H2A and H2B they 
constitute the histone octamer. Neighboring nucleosomes are connected by 10 to 80 bp of 
so called linker DNA. Histone H1 is known as the linker histone, since it binds to the linker 
DNA between two nucleosomes (Figure 4 (B)). In contrast to the four core histones, histone 
H1 is not essential for viability in Saccharomyces cerevisiae (He and Lehming, 2003), 
although in mice and Drosophila severe depletion of histone H1 is fatal (Fan et al., 2003; Lu 
et al., 2009).  
 
Figure 4: Nucleosomes (A) DNA wrapped around the histone octamer. Histone H3 is depicted in 
blue, H4 in green, H2A in yellow and H2B in red. Adapted from Luger et al., 1997. (B) Histone H1 
binds to the nucleosome and the linker DNA. Adapted from Happel and Doenecke, 2009. 
 
The nucleosomes form a “beads-on-a-string” fibre of about 11nm in diameter, with 
nucleosomes as beads and the DNA linking them together as the string. Nucleosomes are 
packaged further into so-called 30nm chromatin fibres which are stabilized by binding of 
histone H1 (Figure 5). 
Introduction 
7 
Figure 5: Chromatin organization. The smallest unit in chromatin is the nucleosome in which DNA 
is wrapped twice around a histone octamer. Nucleosomes are linked together by short stretches of 
DNA. They are packed into 30nm fibres which are further folded into higher order structures. 
Adapted from Felsenfeld and Groudine, 2003. 
 
Core histones are among the most highly conserved eukaryotic proteins known. Histone 
equivalent proteins have even been found in some Archeabacteria (Sandman et al., 1998). 
Originally, it was thought that the main purpose of histones was compacting DNA to fit into 
the nucleus. Today, it is known that histones play fundamentally important roles. 
Nucleosomes compact the genome. However, in doing so, also restrict access of other 
proteins to the DNA and thus gene promoters and therefore are general repressors of 
transcription (Grunstein, 1990).  
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Core histones have a structured globular domain and highly basic flexible tails. The 
globular domain interacts with other histones and the DNA wrapped around it, while the 
unstructured N-terminal tails extend outward from the nucleosome. Each tail is the 
substrate for several post-translational modifications, which can alter chromatin structure, 
compaction and accessibility. 
Chromatin can be broadly divided into two categories depending on its condensation state. 
Heterochromatic regions are highly condensed regions that stay condensed throughout the 
cell cycle and are transcriptionally silent. Lesser condensed regions are called euchromatin. 
The majority of actively expressed genes is located there. In addition to hetero- and 
euchromatin, there are several other chromatin domains displaying distinctive chromatin 
structures, including centromers, Hda1-affected subtelomeric (HAST) domains and Htz1-
activated domains (HAZDs) (Figure 6). Each chromosomal domain is characterized by a 
typical set of distinct histone modifications (Millar and Grunstein, 2006).  
 
Figure 6: Chromatin domains of a Saccharomyces cerevisiae chromosome: (a) Telomeric 
heterochromatin is unacetylated and unmethylated. (b) Centromeric chromatin is hyperacetylated on 
H3K56. Centromeric nucleosomes contain the histone variant CenH3. (c) In Hda1-affected 
subtelomeric (HAST) domains histones H3 and H2A are hypoacetylated at open reading frames 
(ORFs) and histone H3 also at intergenic regions (IGRs). (d) In Htz1-activated domains (HZADs), the 
H2A variant Htz1 is highly enriched in promoter and coding regions. In coding regions, H3K56 is 
hyperacetylated, while at promoters histone H3 is hypoacetylated. (e) Active euchromatic genes are 
methylated at H3K4, H3K36 and H3K79. The 5’ end is hyperacetylated, but not on H4K16. (f) 
Repressed euchromatic genes are hypoacetylated and hypomethylated. Their promoters are often 
more acetylated than the coding regions. Adapted from Millar and Grunstein, 2006. 
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Even within euchromatin, different features, such as promoters and the coding sequences 
of genes, have different patterns of histone modifications. Hence, genes can be divided into 
groups based on their acetylation pattern (Millar and Grunstein, 2006). 
Two classes of enzymes are able to modify chromatin structure: the histone modifiers and 
the ATP-dependent remodelers. Post-translational histone modifications by modifiers can 
lead to an altered interaction with DNA and other histones changing the chromatin 
structure. ATP-dependent remodelers use the energy of ATP hydrolysis to move 
nucleosomes along the DNA, to exchange histones or insert other histone variants 
(Escargueil et al., 2008).  
 
1.3. Histone Modifications 
 
Histones are substrates for at least 8 types of known post-translational modifications: 
acetylation, methylation, phosphorylation, ubiquitylation, sumoylation, ADP ribosylation, 
deimination and proline isomerization (Table 1).  
 
Table 1: Different classes of modifications identified on histones. The functions associated with 
each modification are shown. Adapted from Kouzarides, 2007. 
 
Over 60 different residues of histone proteins are known to be modified (Table 2). Most 
modifications are located on the N-terminal tails of histones, but some can also be found on 
the globular core domain. Of course, not all modifications are present at the same histone 
at the same time, rather a combination of some of the possible modifications will determine 
the function. This concept is referred to as the histone code (Jenuwein and Allis, 2001; 
Strahl and Allis, 2000). Although the histone code has been widely accepted in the last 
decade, it is now heavily disputed. Histone modifications may be only one signal in a signal 
transduction pathway or regulate DNA accessibility (Henikoff and Shilatifard, 2011). 
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Table 2: Modified histone residues. h.s.: Homo sapiens; s.c.: Saccharomyces cerevisiae; NI: 
modification reported but residues not identified. Adapted from Escargueil et al., 2008. 
 
Histones Acetylated 
residues 
Methylated 
residues 
Ubiquitylated 
residues 
Phosphorylated 
residues 
Sumoylated 
residues 
Isomerized 
prolines 
H2A K5 – K119 S1, T120 K126 (s.c.) – 
H2AX – – – T136, S139 (h.s.) – – 
H2B K5, K12, K15, 
K20 
– K120 S14 K6, K7, K16,  
K17 (s.c.) 
– 
H3 K9, K14, K18, 
K23, K27, K56 
R2, K4, R8, K9, 
R17, R26, K27, 
K36, K79 
NI T3, S10, T11, 
S28 
NI P30, P38 
H4 K5, K8, K12, 
K16, K91 (Ye et 
al., 2005) 
 NI S1 K5, K8, K12, 
K16, K20 (s.c.) 
– 
 
Histone modifications function by two mechanisms. They alter the interaction between 
histones and DNA, thereby changing chromatin structure and they regulate recruitment of 
other proteins to the nucleosome. These proteins carry enzymatic activities which can 
further modify histones or recruit proteins involved in transcription, replication or DNA repair 
(Kouzarides, 2007). 
 
1.3.1. Acetylation 
Histone acetylation is almost always associated with transcriptionally active regions of 
chromatin. Histone acetyltransferases (HATs) enzymatically transfer an acetyl group from 
acetyl-CoA to the amino-group of a lysine residue. Most HATs acetylate more than one 
lysine but some specificity has been observed. Acetylation of lysine neutralizes its positive 
charge, thereby weakening its interaction with negatively charged DNA and making the 
DNA more accessible for other proteins (Woodcock and Ghosh, 2010). 
There exist three main families of HATs: the GNAT-superfamily, including Gcn5, PCAF, 
Hat1, Elp3 and Hpa2, the MYST-family, named after its founding members MOZ, 
Ybf2/Sas3, Sas2, and Tip60, and CBP/p300 (Kouzarides, 2007; Sterner and Berger, 2000). 
Furthermore, HATs have been divided into two categories: type A and type B HATs. Type A 
HATs are localized in the nucleus and acetylate histones within chromatin. Type B HATs 
are found in the cytoplasmic fraction of cells and are able to acetylate free but not 
nucleosomal histones. They are believed to acetylate newly synthesized histones before 
their transport into the nucleus (Brownell and Allis, 1996; Garcea and Alberts, 1980). 
As most histone modifications, acetylation is a reversible process. Deacetylation of histones 
is carried out by histone deacetylases (HDACs). There are three families of HDACs: class I 
and class II histone deacetylases and class III NAD-dependent enzymes of the Sir family. 
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They are not specific to certain lysine residues, although some HDACs show specificity 
towards certain histones (Kouzarides, 2007). HDACs often are found in repressive 
chromatin complexes and are involved in several signaling pathways (Kouzarides, 2007). 
They are not only involved in transcriptional regulation, but also in DNA replication, repair 
and heterochromatin formation (Kurdistani and Grunstein, 2003).  
 
1.3.2. Methylation 
Histones can be methylated on lysine and arginine residues. Each lysine can be mono-, di- 
or trimethylated, arginine can be mono- or dimetyhlated (symmetric or asymmetric). Lysine 
methyltransferases are usually very specific and modify only one specific lysine residue. 
Lysine methylation is implicated in both activation and repression of transcription depending 
on the modified residue. H3K4, H3K36 and H3K79 methylation is connected to activation of 
transcription, while H3K9, H3K27 and H4K20 methylation is implicated in repression of 
transcription (Kouzarides, 2007). 
For a long time histone methylation was considered as a permanent mark until the first 
histone demethylase LSD1 (lysine-specific demetylase 1) was discovered (Shi et al., 2004). 
Specificities of histone demethylases are influenced by other proteins with which they form 
complexes, but also depends on the methylation state (Kouzarides, 2007; Shi and 
Whetstine, 2007). 
Finally, the methylation of arginine residues, like lysine methylation, can activate or repress 
transcription depending on the modified residues. Reversal of arginine methylation can 
either be carried out by demethylases or methylarginine can be converted to citrulline by 
deiminases (Chang et al., 2007; Cuthbert et al., 2004; Kouzarides, 2007).  
 
1.3.3. Phosphorylation 
Histone phosphorylation plays an important role in the chromatin condensation and cell 
cycle progression. Furthermore, phosphorylation of histone H2A in budding yeast and 
H2AX in mammalian cells is involved in DNA damage repair. It is one of the first responses 
observed after DNA double strand breaks. Regulation of transcription is influenced by 
phosphorylation as well. Phosphorylation of histone H3S10 can enhance H3K12 acetylation 
and thereby influence transcriptional activity (Ito, 2007; Kouzarides, 2007). 
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1.3.4. Ubiquitination 
Ubiquitin is a 76 amino acid protein, which can be conjugated via its C-terminal glycine to 
lysine residues of any protein. Polyubiquitination marks a protein for degradation by the 
proteasome (Chau et al., 1989; Thrower et al., 2000), whereas monoubiqitylated proteins 
are usually stable (Hicke, 2001). Ubiquitination is involved in endocytosis (Hicke and 
Riezman, 1996; Kolling and Hollenberg, 1994), signaling (Geetha et al., 2005; Gupta-Rossi 
et al., 2004), replication and transcription (Bienko et al., 2005; Kannouche et al., 2004; 
Mukhopadhyay and Riezman, 2007). 
Addition of ubiquitin to histone residues has been linked to regulation of transcription and 
DNA repair. In yeast, ubiquitination of H2BK120 is an activator of transcription, but it has 
also been shown that some enzymes responsible for deubiquitination of histones are 
required for transcriptional activation. Furthermore, ubiquitination of histone H3 and H4 is 
implicated in DNA repair of UV-induced damage (Higashi et al., 2010; Kouzarides, 2007). 
 
1.3.5. Sumoylation 
SUMO (small ubiquitin-like modifier) is a small protein of about 100 amino acids. Its 
structure is similar to ubiquitin even though it shares only ~18% sequence identity 
(Johnson, 2004). Like ubiquitin, it is linked via its C-terminus to a lysine residue of target 
proteins. Sumoylation has been detected on lysine residues of all four core histones. It 
competes with acetylation and ubiquitination, both of which are implicated in the activation 
of transcription, for the same lysine residues and is connected to repression of 
transcription. Desumoylation is carried out by specific SUMO-cleaving enzymes 
(Kouzarides, 2007). 
 
1.3.6. ADP Ribosylation 
Histones can be mono- or poly-ADP ribosylated on lysine residues by mono-ADP-
ribosyltransferases (MARTs) and poly-ADP-ribose polymerases (PARPs), respectively. All 
four core histones can be modified in this way at their N-terminal tails. Addition of ADP-
ribosyl to histones does not only neutralize the positive charge of lysine, it also adds a 
negative charge, and blocks the residue for other kinds of modifications (Messner et al., 
2010). ADP ribosylation has also been linked to regulation of transcription (Kouzarides, 
2007). 
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1.3.7. Deimination 
Arginine residues in histones H3 and H4 can be converted to citrulline by the peptidyl 
arginine deiminase 4 (PADI4). Citrulline can no longer be methylated. Therefore, 
deimination counteracts arginine methylation and its activating effect. Additionally, mono-
methylated arginine can be deiminated as well, thereby removing the methylation mark 
(Cuthbert et al., 2004; Kouzarides, 2007). 
 
1.3.8. Proline Isomerization 
Proline can exist in two conformations: cis and trans. Changing from one conformation to 
the other dramatically affects the structure of a polypeptide backbone. The Saccharomyces 
cerevisiae proline isomerase Fpr4 isomerizes H3P30 and H3P38 from cis to trans in vitro. 
Since the appropriate proline isomer is necessary for recognition by the Set2 
methyltransferase, Fpr4 activity regulates the amount of H3K36 methylation, thereby 
affecting transcription (Kouzarides, 2007; Nelson et al., 2006). 
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1.4. Histone Modification and Processing after Synthesis 
 
Histones are not only modified after their incorporation into chromatin. Newly synthesized 
histones are also processed before their assembly into nucleosomes. Both histones H3 and 
H4 are acetylated after synthesis, a modification that is removed during chromatin 
maturation (Annunziato and Hansen, 2000; Jackson et al., 1976). The ability of type B 
HATs to acetylate free histones makes them the most likely enzyme to carry out this task. 
 
1.4.1. Hat1, the Only Type B Histone Acetyltransferase 
Hat1 was the first histone acetyltransferase identified, and remains the only type B HAT 
known. Hat1 was isolated from cytoplasm and found to acetylate free histone H4, but not 
nucleosomal histones. Lysine 5 and 12 in the N-terminal tail of histone H4 are acetylated on 
newly synthesized histones, a pattern that is highly conserved in eukaryotes (Sobel et al., 
1995). Native Hat1 isolated from yeast acetylates histone H4 lysine 12, while recombinant 
Hat1 is capable of acetylating H4K5 and H4K12 (Parthun et al., 1996). Although lysines 8 
and 16 are not acetylated themselves, it seems their positive charge is important for 
substrate binding to Hat1 (Benson et al., 2007). 
 
In yeast, Hat1 co-purifies with another protein, Hat2. Hat2 is a WD40 repeat protein and a 
homologue to mammalian Rbap46/48 proteins. In vitro experiments showed that 
association of Hat2 with Hat1 increases its catalytic activity ten-fold (Parthun et al., 1996). 
This complex composition is evolutionary conserved, as purification of type B histone 
acetyltransferase complexes from human, Xenopus laevis, chicken and maize all contain a 
catalytic subunit similar to Hat1, as well as a second subunit similar to Hat2 (Ahmad et al., 
2000; Chang et al., 1997; Eberharter et al., 1996; Imhof and Wolffe, 1999; Verreault et al., 
1998). This complex is often referred to as the HAT-B complex. 
 
In Saccharomyces cerevisiae, it was shown that Hat1, despite being classified as a type B 
HAT, is not only found in the cytoplasm but also in the nucleus (Ai and Parthun, 2004; 
Poveda et al., 2004). Deletion of HAT1 leads to the loss of the histone H4-specific 
acetyltransferase activity in cytoplasmic, as well as nuclear fractions (Ruiz-Garcia et al., 
1998). Epitope-tagging and immunofluorescent labeling show that Hat1 and Hat2 are 
mainly localized in the nucleus (Poveda et al., 2004). 
 
The Saccharomyces cerevisiae nuclear HAT-B complex, referred to as NuB4 complex, 
contains Hif1 (Hat1 Interacting Factor 1) in addition to Hat1 and Hat2. Hif1 is a histone 
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chaperone specific for histone H3 and H4 and functions in chromatin assembly (Ai and 
Parthun, 2004). Interaction of Hif1 with Hat1 is mediated by Hat2, as in the absence of 
Hat2, the Hat1 and Hif1 interaction is lost (Poveda et al., 2004). Furthermore, the nuclear 
localization of Hat1 depends on Hat2, but not on Hif1 (Poveda et al., 2004). In contrast, 
localization of Hat2 and Hif1 are independent of Hat1 and of each other (Poveda et al., 
2004).  
 
Surprisingly, even though acetylation of H4K5 and H4K12 is highly conserved in 
eukaryotes, it is not essential in Saccharomyces cerevisiae (Ma et al., 1998). Neither 
mutating lysines 5 and 12 to arginine to mimic the unacetylated state, nor deleting HAT1 
results in a significant phenotype. Only in combination with the deletion of the N-terminal 
tail of histone H3 or mutation of specific lysine residues in it, an effect can be seen. Deletion 
of the H3 N-terminus together with altering the histone H4 N-terminal lysines causes a loss 
of nucleosome assembly and cell death. Deletion of HAT1 together with specific 
substitutions of lysines in the histone H3 N-terminal tail causes a defect in telomeric 
silencing and in the repair of DNA double-strand breaks (Kelly et al., 2000; Qin and 
Parthun, 2002). A similar phenotype is observed when the histone H3 mutations are 
combined with deletions of HAT2 or HIF1 (Kelly et al., 2000; Poveda et al., 2004). The in 
vivo acetylation level of H4K12 is not affected by deletion of HAT1, HAT2 or HIF1 (Poveda 
et al., 2004). This can be explained by the fact that the acetylation of H4K12 by Hat1 is only 
a transient modification and therefore does not contribute to a significant extend to the total 
steady-state level of H4K12 acetylation.  
 
In response to DNA double strand breaks (DSB), Hat1 is recruited to the site of DNA 
damage, and H4K12 acetylation levels in the regions surrounding the DSB increase (Qin 
and Parthun, 2006). Since Hat1 is unable to acetylate nucleosomal histones, it may 
participate in a histone exchange process, in which histone H3/H4 tetramers are replaced. 
Interestingly, recruitment of Hat1 to the site of DNA damage does not require repair of the 
DSB, suggesting that Hat1 may be directly involved in the DNA repair process rather than 
only in the restoration of chromatin structure after repair is complete (Qin and Parthun, 
2006). However, deletion of HAT1 also causes a significant defect in the repair-linked 
chromatin reassembly. Surprisingly, loss of Hat2 results only in a minor defect. It is possible 
that in this process Hat1 does not depend strongly on its catalytic activity or that the 
influence of Hat2 in vivo is not that strong. Alternatively, Hat1 may have the ability to modify 
other substrates for which Hat2 is not required (Ge et al., 2011). 
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1.4.2. Rtt109, a Histone H3 Specific Histone Acetyltransferase 
Histone H3, just like histone H4, is acetylated after synthesis (Masumoto et al., 2005). 
Unlike histone H4 with its highly conserved pattern of modifications, acetylation sites of 
histone H3 vary between different organisms. In Drosophila and Tetrahymena, deposition-
related acetylation is associated with H3K14/23 and H3K9/14, respectively (Sobel et al., 
1995). In Saccharomyces cerevisiae, newly synthesized histone H3 is acetylated on lysine 
9 (Kuo et al., 1996). But not only residues on the N-terminal tail can be modified. Lysine 
residues in the globular domain can be acetylated as well. In Saccharomyces cerevisiae 
and Schizosaccharomyces pombe, newly synthesized histones H3 are abundantly 
acetylated on lysine 56 (Han et al., 2007; Xhemalce et al., 2007). This acetylation mark 
persists after incorporation into chromatin until the G2/M-phase when lysine 56 is 
deacetylated by HDACs Hst3 and Hst4 (Celic et al., 2006). 
 
The Saccharomyces cerevisiae histone acetyltransferase Rtt109 acetylates several lysines 
on histone H3. Its specificity is controlled by the histone chaperones Asf1 and Vps75. 
Rtt109-Asf1 has strong site specificity for H3K56, while Rtt109 in a complex with Vps75 
acetylates H3K56 and H3K9. Further addition of Asf1 to this complex enhances the 
acetylation activity of Rtt109 (Fillingham et al., 2008). Deletion of RTT109 leads to a 
complete loss of H3K56 acetylation, suggesting that Rtt109 is the only H3K56 HAT in 
Saccharomyces cerevisiae. Similarly, deletion of ASF1 results in complete loss of H3K56 
acetylation, whereas the acetylation level of H3K56 in cells lacking Vps75 remains normal. 
The acetylation level of H3K9 in cells lacking Rtt109, Asf1 or Vps75 is reduced. H3K9 is not 
only acetylated by Rtt109 but also by the HAT Gcn5. Deleting GCN5 in combination with 
either RTT109, ASF1 or VPS75 results in a complete loss of H3K9 acetylation, suggesting 
that Rtt109, Asf1 and Vps75 function together in a Gcn5-independent pathway (Fillingham 
et al., 2008). 
 
Acetylation of H3K56 by Rtt109 is required for genome stability, resistance to DNA-
damaging agents, chromatin reassembly after DNA damage repair and deposition of newly 
synthesized histones into chromatin (Chen et al., 2008; Driscoll et al., 2007; Han et al., 
2007; Li et al., 2008; Masumoto et al., 2005; Tsubota et al., 2007). Cells depleted for Rtt109 
or Asf1 are highly sensitive to DSBs causing agents, and exhibit an elevated level of 
spontaneous chromosome breaks (Driscoll et al., 2007; Fillingham et al., 2008; Han et al., 
2007). 
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1.4.3. Histone Processing by Hat1 and Rtt109 
Newly synthesized histones are modified, transported into the nucleus and finally deposited 
into chromatin. Even though many proteins involved in this process have been identified, 
the mechanism as a whole remains poorly understood. A working model of histone H3 and 
H4 processing in Saccharomyces cerevisiae is depicted in Figure 7. First, histone H4 is 
bound and acetylated at lysine 5 and 12 by the Hat1/Hat2 complex in the cytoplasm. 
Histone H4 is not released after acetylation but remains bound to the Hat1/Hat2 complex. 
At some point during this process histone H3 becomes associated. The Hat1/Hat2/H3/H4 
complex is then imported into the nucleus by karyopherins such as Kap123. In the nucleus, 
Hif1 becomes associated forming the NuB4 complex. Histones H3 and H4 are then 
transferred from Hif1 to the histone chaperone Asf1. After that, Asf1 can recruit Rtt109 or 
Rtt109/Vps75, which in turn acetylates histone H3 on lysine 9 and 56. In the last step, 
histones H3 and H4 are deposited into chromatin (Campos et al., 2010; Fillingham et al., 
2008; Parthun, 2007). 
 
Figure 7: Model illustrating the roles of histone chaperones and HATs during chromatin 
assembly. Adapted from Fillingham et al., 2008. 
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1.5. Aims of this Diploma Thesis 
 
Candida albicans is an important human fungal pathogen with several distinct growth 
forms. Filamentation is considered a major virulence trait and can be induced by various 
environmental or host stimuli. For instance, treatment of Candida albicans with genotoxic 
agents or depletion of components involved in the DNA damage response can trigger 
pseudohyphal growth. In the yeast Saccharomyces cerevisiae, the histone 
acetyltransferases Hat1, which forms a complex with the subunit Hat2, and Rtt109, which 
interacts with Asf1, are both implicated in DNA damage repair. We therefore analyzed the 
roles of Hat1/Hat2 and Rtt109/Asf1 in Candida albicans. 
 
The major aims of this thesis were: 
 
- To raise antibodies as a tool for the characterization of Hat1 and Hat2 function. 
 
- Moreover, Hat2 should be epitope-tagged with a fluorescent protein to investigate its 
intracellular localization, its dependence on Hat1 and the influence of DNA-damaging 
agents. 
 
- Furthermore, deletion strains of RTT109 and ASF1 should be constructed to investigate 
their function in Candida albicans. 
 
- Finally, strains with mutated histone H4 variants that would mimic the acetylated or 
unacetylated state of Hat1-targeted lysine residues should be constructed. 
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2. Material & Methods 
2.1. Basic Bacteriological Methods 
2.1.1. Media for E. coli 
1x LB: 
10g/l Tryptone 
5g/l Yeast extract 
10g/l NaCl 
For LB-plates, add bacteriological agar (BD) at a final concentration of 2% (w/v).  
For LB+Amp medium, add ampicillin after autoclaving at a final concentration of 120µg/ml. 
For LB+chloramphenicol medium, add chloramphenicol after autoclaving at a final 
concentration of 40µg/ml in plates and 50µg/ml in liquid culture. 
 
2.1.2. Competent E. coli 
• Grow o/n culture E. coli in 500ml S.O.B. medium at 18°C or room temperature to 
OD600=1. 
• Chill culture on ice for 20min. 
• Spin down at 2500rpm 10min 4°C (50ml falcons). 
• Gently resuspend pellet in 10ml ice-cold TB. 
• Put on ice for 10min. 
• Spin down at 2500rpm 10min 4°C in a microfuge. 
• Resuspend in 35ml ice-cold TB. 
• Add DMSO (Sigma, tissue culture grade) to a final concentration of 7% (v/v). 
• Put on ice for 10min. 
• Freeze 500µl aliquots in liquid nitrogen and store at -80°C. 
 
S.O.B. medium: 2%  Tryptone (w/v) 
0.5%  Yeast extract 
10mM  NaCl 
2.5mM  KCl 
20mM  MgCl2 
Dissolve tryptone yeast extract and NaCl in dH2O, add 
KCl, adjust pH to 7.5 with NaOH, autoclave and add 
sterile MgCl2. 
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TB: 10mM  Pipes 
55mM  MnCl2 
15mM  CaCl2 
250mM  KCl 
Mix all components except MnCl2 in dH2O, adjust to pH 
6.7 with KOH, add MnCl2, sterilize by filtration through a 
0.45µm Millipore filter and store at 4°C. 
 
2.1.3. E. coli Transformation 
• Slowly thaw competent cells on ice. 
• Gently mix 1-10μl DNA with 100µl competent cells. 
• Incubate on ice for 30min. 
• Heat shock cells at 42°C for 45sec. 
• Cool on ice for 2min. 
• Add 900µl S.O.C. medium. 
• Incubate at 37°C for 1 hour. 
• Plate cells on a selective LB plate and incubate at 37°C overnight.  
 
S.O.C. medium: 2%  Tryptone 
0.5%  Yeast extract 
2.5mM  KCl 
10mM  MgSO4 
20mM  Glucose 
10mM  NaCl 
10mM  MgCl2 
 
2.2. Basic Yeast Methods 
2.2.1. Media for Yeast 
1x YPD: 
10g/l  Yeast extract (BD) 
20g/l Peptone (BD) 
2% Glucose (w/v) 
For YPD-plates, add bacteriological agar (BD) at a final concentration of 2% (w/v). 
For YPD+NAT medium, add nourseothricin after autoclaving at a final concentration of 
300µg/ml in plates and 150µg/ml in liquid culture. 
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1x SC: 
6.7g/l  Bacto-YNB w/o amino acids and (NH4)2SO4 (DIFCO) 
5g/l Ammonium sulfate 
2%  Glucose 
1.43g/l Amino acid mix 
If required add uracil, histidine and leucine at a final concentration of 4mg/l uracil, 6mg/l 
histidine and 26mg/l leucine. For SC-plates, add bacteriological agar at a final 
concentration of 2% (w/v). 
 
Amino acid mix (Sigma; g/29g): 0.4g  Arginine  
0.6g  Tyrosine  
0.6g  Isoleucine  
0.8g  Adenine  
1.0g  Phenylalanine  
2.0g Glutamic acid  
2.0g  Aspartic acid  
3.0g  Valine  
3.0g  Methionine  
3.6g  Lysine  
4.0g  Threonine  
8.0g  Serine 
 
1x MM (minimal medium): 
6.7g/l  Bacto-YNB w/o amino acids and (NH4)2SO4 (DIFCO) 
5g/l Ammonium sulfate 
2%  Glucose 
For MM-plates add bacteriological agar (BD) at a final concentration of 2% (w/v). 
 
2.2.2. Preparation of Yeast TCA Extracts for Immunoblotting 
• Dilute o/n culture in 5ml YPD. 
• Harvest cells with OD600=0.8-1 by spinning 5min at 3000rpm. 
• Resuspend cells in 1ml H2O. 
• Add 150µl Yex-lysis buffer and vortex. 
• Incubate 10min on ice. 
• Add 150µl cold 50% (w/V) TCA (trichloracetic acid). 
• Incubate at least 10min on ice. 
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• Spin 5min 13000rpm 4°C. 
• Discard supernatant. 
• Spin again. 
• Carefully take off supernatant. 
• Resuspend pellet in protein sample buffer (20µl/OD600). 
• Incubate 15min at 37°C on shaker (700rpm). 
• Spin down cell debris 5min at 13000rpm. 
• Load 10µl (0.5 OD600) of supernatant on SDS-PAGE gel. 
 
Yex-lysis buffer:  1.85M NaOH 
7.5% β-mercaptoethanol (v/v) (freshly added) 
 
Protein sample buffer: 40mM Tris-HCl pH 6.8 
8M Urea 
5% SDS (w/v) 
0.1mM EDTA 
1% β-mercaptoethanol (v/v) (freshly added) 
0.1g/l Bromophenol blue 
0.1M Tris base (Trizma® base) 
 
2.2.3. Preparation of Genomic Yeast DNA 
• Grow 5ml yeast cultures overnight to saturation in appropriate media at 30°C. 
• Sediment cells for 5min at 1500rpm (Beckmann). 
• Resuspend cells in 0.5ml sterile distilled water. 
• Transfer the cells to 1.5ml tube. 
• Spin down cells for 5sec in the Eppendorf centrifuge at the maximum speed 
(14000rpm). 
• Decant the supernatant and briefly vortex the pellet in 200µl Yeast Lysis Buffer. 
• Add 200µl PCI and 0.3g of acid-washed glass beads (Sigma). 
• Disrupt cells in FastPrep (FastPrep®-24, MP Biomedicals) for 45sec, 6m/sec. 
• Add 200µl TE pH 8. 
• Spin for 5min and transfer aqueous phase to a new tube.  
• Add 1ml 100% EtOH, mix by inversion and incubate at -20°C for 20min. 
• Spin for 10min at 4°C, and aspirate the supernatant.  
• Resuspend the pellet in 400µl TE and 4µl RNase A (Boerhinger Mannheim). 
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• Incubate at 37°C until the pellet is dissolved. 
• Add 10µl 4M ammonium acetate and 1ml 100% EtOH. Incubate 20min at -20°C. 
• Spin for 10min at 4°C and discard the supernatant. Wash with 1ml 70% EtOH. 
• Air-dry the pellet and resuspend in 50µl TE or water. 
 
PCI: Phenol:chloroform:isoamyl alcohol (25:24:1) 
 
1x TE:  10mM  Tris-HCl pH 8.0 
 1mM  EDTA 
 
Yeast Lysis Buffer (Winston Lysis Buffer):  
100mM  NaCl 
10mM  Tris-HCl pH 8 
1mM  EDTA 
2%  Triton X-100 
1%  SDS 
 
2.2.4. Transformation by Electroporation 
• Dilute overnight culture in 50ml YPD and grow at 30°C to OD600=~1.5. 
• Harvest at 2500rpm (1000g Eppendorf) for 5min. 
• Wash with 25ml H2O (vortex). 
• Resuspend in 8ml H2O, 1ml 10x TE and 1ml 1M lithium acetate. 
• Incubate 60min at 30°C, 150rpm. 
• Add 250µl 1M DTT (keep DTT on 4°C). 
• Incubate 30min at 30°C, 150rpm. 
• Add 40ml H2O (cold). 
• Centrifuge at 2500rpm (1000g) 5min 4°C. 
• Resuspend in 25ml cold H2O by gentle shaking. 
• Centrifuge at 2900rpm (1000g) 5min 4°C. 
• Wash pellet in 5ml cold 1M Sorbitol. 
• Resuspend pellet in 550µl 1M Sorbitol. 
• Sterilize clean electroporation cuvettes by 3x autocrosslink in Stratagene crosslinker. 
• Cool electroporation cuvettes on ice. 
• Transfer 10µl DNA deletion construct into electroporation cuvette. 
• Transfer 100µl of competent cells into electroporation cuvette. 
• Leave on ice for 5-10min. 
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• Electroporator settings: BioRad gene pulser (200Ω, 1.5kV, 25µF) 
Time constant should be ~4.6ms. 
• Add 950µl YPD. 
• Transfer to 15ml tube and shake at 30°C for 4 hours. 
• Plate on YPD-Nat. 
• Incubate at 30°C for 1-2 days. 
 
10x TE:  100mM  Tris-HCl pH 8.0 
 10mM  EDTA 
 
2.2.5. Colony PCR 
• Pick cells with a sterile toothpick and resuspend in 40µl PCR-mix 1: 
5µl  10x PCR buffer 
3µl  50mM MgCl2 
32µl  dH2O 
• Break cells by incubating at 93°C for 10min. 
• Add 10µl PCR-mix 2: 
4µl  dNTPs (2.5mM each) 
2.5µl Forward primer (10µM) 
2.5µl Reverse primer (10µM) 
1µl  Taq polymerase 
• PCR-program: 
93°C 3’ 00’’ denaturation    
93°C 30’’ denaturation    
TM 30’’ primer annealing 35 cycles  TM: melting temperature primers 
72°C x’’ extension   2’ for 1kb 
72°C 10’ 00’’ final extension    
10°C  hold    
 
10x PCR buffer: 500mM  KCl 
100mM  Tris-HCl pH 9.0 
1%  TritionX-100 
15mM  MgCl2 
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2.2.6. Spotting Assay on Agar Plates 
• Dilute overnight cultures to OD600=0.1 and grow for several hours at 30°C. 
• Prepare agar plates (2% bact. agar (BD)) containing substances for sensitivity testing. 
• Dilute culture to OD600=0.1 in 200µl dH2O. 
• Make 1:5 serial dilutions by adding 40µl of one dilution to 160µl H2O. 
• Spot 3µl of each dilution on plates and incubate for 2 to 5 days at 30°C. 
 
2.2.7. Microscopy 
Single cell pictures: 
• Dilute o/n culture in fresh YPD and grow cells at 30°C for several hours. 
• For nuclear staining add Hoechst33342 to a final concentration of 2µg/ml for 1 hour. 
• Spin down cells. 
• Wash with PBS. 
• Take up cells in PBS. 
• Cells are examined using an Olympus cellR - Imaging Station. Pictures were taken with 
a Hamamatsu ORCA-ER digital camera. 
 
Colony pictures: 
• Plate cells on YPD and let grow for 2-3 days at 30°C. 
• Colony pictures are taken with a Discovery.V12 Stereomicroscope and an AxioCam 
MRc5 (Zeiss). 
 
2.3. DNA Methods 
2.3.1. Agarose Gel Electrophoresis 
• Mix DNA samples (5-50μl) with an appropriate amount of 6x DNA loading buffer. 
• Load samples on a gel containing 0.7-2% agarose in 1x TBE buffer and 0.5μg/ml 
ethidium bromide, in electrophoresis chamber filled with 1x TBE buffer. 
• Load 3μl molecular weight standard on the gel (Bioline Hyperladder I or Fermentas 
GeneRuler™ 1kb Plus DNA Ladder). 
• Separate DNA fragments in an electric field with 90V. 
• Visualize nucleic acid fragments under UV-light. 
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1x TBE: 89mM Tris base 
89mM Boric acid 
2mM EDTA 
 
6x DNA loading buffer: 0.25% Bromophenol blue (w/v) 
0.25% Xylenecyanol FF (w/v) 
30% Glycerol (v/v) 
 
2.3.2. Molecular Biology Cloning Procedures 
Restriction enzyme digest: 
• Digest DNA in a total volume of 100μl using the proper buffer supplied with the enzyme 
using conditions recommended by the manufacturer (Fermentas or NEB). 
 
Phosphatase treatment: 
• After restriction digest add 2μl FastAP™ Thermosensitive Alkaline Phosphatase (1U/µl, 
Fermentas) to the reaction mix.  
• Incubate 60min at 37°C. 
 
Gel elution: 
• Load reaction mix on a gel to elute the fragment.  
• Cut the desired DNA fragment out of the gel.  
• Elute DNA from gel using the peqGOLD Gel Extraction Kit (peqlab) according to 
manufacturer’s instructions.  
 
Ligation of DNA fragments: 
• Vector and insert are ligated with T4 DNA ligase (1U/µl, Roche) at a molar ratio of 1:3 or 
1:5.  
• Ligation mix: 10μl total  
50ng Vector DNA 
x μl  Insert  
1μl  10x ligation buffer 
1μl  T4 DNA ligase  
• Incubate ligation mix for 60min at room temperature before transforming 5μl into 
competent E. coli cells. 
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2.3.3. Plasmid Mini Preparation 
• Grow E. coli cells containing the plasmid in 5ml LB+antibotic at 37°C overnight. 
• Harvest cells in 2ml tube. 
• Resuspend pellet in 250µl buffer P1 (QUIAGEN). 
• Add 250µl buffer P2 (QUIAGEN) and mix by inverting. 
• Add 350µl buffer P3 (QUIAGEN) and mix by inverting. 
• Incubate 5min on ice. 
• Centrifuge 5min at 13000rpm 4°C. 
• Transfer supernatant to new tube. 
• Add 0.7x volume isopropanol (-20°C). 
• Incubate 15min on ice. 
• Centrifuge 10min at 13000rpm 4°C. 
• Discard supernatant. 
• Wash with 1ml 70% EtOH (-20°C). 
• Dry at 55°C. 
• Resuspend in 100µl dH2O. 
 
Buffer P1 (resuspension buffer): 50mM  Tris-HCl pH 8.0 
10mM  EDTA 
100μg/ml  RNase A 
 
Buffer P2 (lysis buffer): 200mM  NaOH 
1%  SDS (w/v) 
 
Buffer P3 (neutralization buffer): 3M  Potassium acetate pH 5.5 
 
2.3.4. DNA Precipitation 
• Add 1/10 of the original volume of 3M Na-acetate pH 5.3 and 3 times the volume of 
EtOH. 
• Incubate at -20°C for 1 hour. 
• Spin down for 15min at 4°C. 
• Wash with 70°C. 
• Dry pellet at 50°C. 
• Resuspend pellet in appropriate amount of dH2O. 
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2.3.5. DNA-Sequencing 
DNA sequencing was carried out by the I.M.P. Sequencing Service. 
 
2.3.6. PCR 
Reaction mix: 50µl total volume 
10ng Template 
10µl 5x Phusion® HF Buffer (Finnzymes) 
4µl dNTPs (2.5mM each) 
2.5µl Forward primer (10µM) 
2.5µl Reverse primer (10µM) 
0.3µl Phusion® High-Fidelity DNA Polymerase (2U/µl) (Finnzymes) 
 
PCR-program: 
98°C 30’’ denaturation    
98°C 10’’ denaturation    
TM+3°C 30’’ primer annealing 35 cycles  TM: melting temperature primers 
72°C x’’ extension   30’’ for 1kb 
72°C 3’ 00’’ final extension    
10°C  hold    
 
2.3.7. Fusion PCR 
To obtain tagging cassettes purified overlapping PCR-fragments were mixed at a molar 
ratio of 1:1 and amplified using appropriate primers. 
 
Reaction mix: 50µl total volume 
overlapping PCR-fragments as template 
5µl 10x Ex TaqTM Buffer (Mg2+ plus) (TaKaRa) 
4µl dNTPs (2.5mM each) 
2.5µl Forward primer (10µM) 
2.5µl Reverse primer (10µM) 
0.5µl Ex TaqTM Polymerase (5U/µl) (TaKaRa) 
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PCR-program: 
93°C 3’ 00’’ denaturation    
93°C 30’’ denaturation    
TM 30’’ primer annealing 30 cycles  TM: melting temperature primers 
72°C x’’ extension   1’ for 1kb 
72°C 10’ 00’’ final extension    
10°C  hold    
 
2.3.8. Site-Directed Mutagenesis 
• Set up two separate primer extension reactions, one for the forward and one for the 
reverse primer. 
 
Reaction mix: 50µl total volume 
100ng  Plasmid template 
10µl 5x Phusion® HF Buffer (Finnzymes) 
4µl dNTPs (2.5mM each) 
2.5µl Forward or reverse primer (10µM) 
0.3µl Phusion® High-Fidelity DNA Polymerase (2U/µl) (Finnzymes) 
 
PCR-program: 
98°C 30’’ denaturation    
98°C 10’’ denaturation    
60°C 30’’ primer annealing 4 cycles   
72°C x’’ extension   30’’ for 1kb 
72°C 3’ 00’’ final extension    
10°C  hold    
 
• Combine 25µl from each extension reaction above.  
• Incubate as above, except repeat a total of 18 cycles. 
• Transfer 25µl of the reaction to a microcentrifuge tube. 
• Add 1µl DpnI restriction enzyme (Fermentas, 10 U/µl).  
• Mix well and incubate at 37°C for 1-2 hours. 
• After the first incubation step add again 1µl DpnI and incubate another 1-2 hours. 
• Transform 1-5µl of the reaction into competent E. coli. 
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2.3.9. Quantitative PCR 
Quantitative PCR was performed in triplicates on a Realplex Mastercycler (Eppendorf) 
using the KAPA SYBR® FAST qPCR Kit (Kapa Biosystems).  
 
Reaction mix: 20µl total volume 
3µl Template (2.5ng/µl genomic DNA) 
0.3µl Primer mix (25µM each) 
10µl KAPA SYBR® FAST qPCR MasterMix 2x 
0.4µl KAPA SYBR® FAST ROX Low 50x 
 
PCR-program: 
95°C 5’ 00’’ denaturation    
95°C 10’’ denaturation    
62°C 10’’ primer annealing 40 cycles   
72°C 15’’ extension    
95°C 20’’ denaturation    
62°C-95°C 30’ 00’’ melting curve    
25°C  hold    
 
For analysis the Realplex 2.0 program (Eppendorf) was used. Data analysis was done 
according to Pfaffl, 2001. 
 
2.3.10. Southern Blot 
• Isolate genomic DNA. 
• Measure concentration of genomic DNA. 
• Digest 25µg genomic DNA overnight using conditions recommended by the 
manufacturer. 
 
Agarose gel for electrophoresis of genomic DNA: 
• Pour a big gel containing 0.7% agarose in 1xTBE. 
• Load genomic DNA samples and molecular weight standard. 
• Apply electric field of 60-80 volts. 
• Take a photo of the gel. 
• Mark bands of molecular weight standard on the gel with a sterile glass pipette. 
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Denaturation and neutralization of agarose gel: 
• Soak agarose gel for 1h in 0.5M NaOH, 1.5M NaCl. 
• Soak agarose gel for 1h in 0.5M Tris-HCl pH 7.5, 1.5M NaCl. 
 
Capillary blotting: 
• Prepare blotting stock in a glass tray as follows: 
Gel tray upside down 
1 Long piece of Whatman-3MM paper soaked in 20xSSC 
1 Piece of Whatman-3MM paper soaked in 20xSSC 
Agarose gel (upside down) 
Nylon membrane (Nylon Membranes, positively charged from Roche) soaked in 
20xSSC 
Put pieces of Parafilm at the sides to seal blot 
1 Piece of Whatman-3MM paper 
Stack of green towels 
Put a 1kg weight on top. 
• Fill glass tray with 20xSSC. 
• Transfer overnight. 
• Mark bands of molecular weight standard on the membrane with a pencil. 
• Crosslink DNA on the membrane using Stratagene UV Crosslinker (auto-crosslink). 
• Rinse membrane briefly with dH2O and allow to air-dry. 
 
Detection: 
Detect DNA fragments using DIG High Prime DNA Labeling and Detection Starter Kit II 
(Roche) according to the manufacturer’s instructions. 
 
20xSSC: 3M  NaCl pH 7.0 
300mM  Sodium citrate 
 
Material & Methods 
32 
2.4. Protein Methods 
2.4.1. SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
• Load samples and 5µl PageRuler™ Plus Prestained Protein Ladder (Fermentas). 
• Run gel at 180V in 1x running buffer. 
 stacking gel separation gel 
 4.5% 12% 15% 16% 
dH2O 1.500ml 1.750ml 1.250ml 1.100ml 
1.5M Tris HCl (pH 8.8) - 1.250ml 1.250ml 1.250ml 
0.5M Tris HCl (pH 6.8) 0.625ml - - - 
30% Acrylamide (Bio-Rad) 0.375ml 2.000ml 2.500ml 2.650ml 
10% SDS 0.050ml 0.050ml 0.050ml 0.050ml 
10% APS 0.025ml 0.050ml 0.050ml 0.050ml 
TEMED 0.003ml 0.005ml 0.005ml 0.005ml 
 
Running buffer: 25mM  Tris 
192mM  Glycine 
0.1%  SDS 
 
2.4.2. Coomassie-Staining of Protein Gels 
• Stain protein gel by shaking for 30min in Coomassie-staining solution. 
• Replace staining solution with dH2O and heat in the microwave oven for a few seconds. 
• Shake for 15min. 
• Repeat until background is destained. 
 
Coomassie staining solution: 10% Acetic acid  
25% Isopropanol  
0.031% Coomassie Brilliant Blue G-250 
 
2.4.3. Silver-Staining of Protein Gels 
• Fix gel by shaking in fixing solution for 1h. 
• Wash three times for 20min with 50% EtOH. 
• Incubate the gel in pre-treatment solution for 1min. 
• Wash three times for 20sec with dH2O. 
• Stain gel by shaking in staining solution for 20min in the dark. 
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• Wash twice for 20sec with dH2O. 
• Incubate gel in developing solution until bands appear. 
• Wash twice for 2min with dH2O. 
• Stop the developing with stopping solution. 
• Wash with 50% MeOH. 
 
Fixing solution: 50%  MeOH 
12%  CH3COOH 
0.5ml/l  37% HCOH 
 
Pre-treatment solution: 0.2g/l  Na2S2O3.5H2O 
 
Staining solution: 2g/l  AgNO3 
0.5ml/l  37% HCOH 
 
Developing solution: 60g/l  Na2CO3 
0.5ml/l  37% HCOH 
4mg/l  Na2S2O3.5H2O 
 
Stopping solution: 50%  MeOH 
12%  CH3COOH 
 
2.4.4. Western Blot 
• Prepare blotting stock as follows:  
Anode 
Whatman-paper soaked in transfer buffer 
Membrane (Whatman® Protran® Nitrocellulose Membrane) moisturized with transfer 
buffer 
Gel 
Whatman-paper soaked in transfer buffer 
Cathode  
• Blot for 1h at 200mA with the Mini Trans-Blot cell (Bio-Rad) in transfer buffer. 
• Detect proteins on membrane with Ponceau S (SIGMA). 
• Destain the membrane by washing in H2O. 
• Block unspecific binding by shaking in blocking solution. 
• Incubate overnight at 4°C with the primary antibody diluted in TBS-T.  
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• Wash three times for 15min with TBS-T. 
• Incubate 1h with the secondary antibody diluted in TBS-T.  
• Wash three times for 15min with TBS-T. 
• Wash with 1x PBS. 
• Scan membrane using the Odyssey® Infrared Imaging System. 
 
Transfer buffer: 25mM Tris 
192mM Glycine 
20% MeOH 
 
Blocking solution: 5% BSA 
1x TBS 
 
TBS: 140mM NaCl 
2.5mM KCl 
25mM Tris pH 7.5 
 
TBS-T: 1x TBS 
0.1% Tween-20 
 
PBS: 140mM NaCl  
2.5mM KCl 
8.1mM Na2HPO4 
1.5mM KH2PO4 pH 7.3 
 
2.4.5. Purification of GST-Fusion Protein from E. coli 
Induction in total extracts:  
• Dilute overnight culture in fresh 20ml LB+Amp to OD600=0.25-0.5. 
• Incubate for 30min at 30°C to equilibrate. 
• Take a 1.5ml control sample at t=0min as the uninduced control. 
• Induce protein expression by adding IPTG at a final concentration of 0.2-1mM. 
• Incubate at 30°C for 4 hours. 
• Take 1.5ml samples at different time points (20-240min). 
• Spin down samples and discard supernatant. 
• Resuspend pellet in protein sample buffer. 
• Boil for 10min on heat block (95°C). 
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• Spin down at 13000rpm for 15min. 
• Run 0.2-1 OD600 equivalents of the total extract on SDS-PAGE gel. 
• Stain with Coomassie Blue. 
 
Determine if GST fusion-protein is soluble or not:  
• Dilute overnight culture in fresh 20ml LB+Amp to OD600=0.25-0.5. 
• Incubate for 30min at 30°C to equilibrate. 
• Take a 1.5ml control sample at t=0min as the uninduced control. 
• Induce protein expression by adding IPTG at a final concentration of 0.2-1mM. 
• Incubate at 30°C for the optimal time. 
• Spin down cells (15ml) for 15min at full speed and wash once with cold PBS. 
• Suspend cells in 1ml cold PBS. 
• Lyse cell suspension by sonicating 3 times for 15 imp, cycle 70% (sonicator: Bandelin 
electronics, UW70, tip SH70). 
• Transfer to 1.5ml Eppendorf tube. 
• Spin homogenate for 10 min at 6700g at 4°C to pellet insoluble inclusion bodies (IB). 
• Take sample from supernatant (soluble fraction) and add sample buffer (same volume). 
• Resuspend insoluble fraction in sample buffer (10µl/OD600). 
• Boil all samples for 10min at 95°C. 
• Run 5µl of total extracts (0.2 OD600) and insoluble fraction (0.5 OD600) and 8µl of 
supernatant on SDS-PAGE gel. 
• Stain with Coomassie Blue. 
 
Binding of GST fusion-protein to glutathione sepharose beads (large scale):  
• Dilute overnight culture in 500ml LB+Amp to OD600=0.5. 
• Incubate for 60min at 30°C to equilibrate. 
• Take a 1.5ml control sample at t=0min as the uninduced control. 
• Induce protein expression by adding IPTG at a final concentration of 0.2-1mM. 
• Incubate at 30°C for 2 hours. 
• Harvest cells by centrifugation at 4000rpm for 5min in a GS3 rotor in a Sorvall 
centrifuge. 
• Resuspend pellet in 3.5ml TpG buffer and add protease inhibitor cocktail (Roche). 
• Lyse cells by sonication (5x 10imp, cycle 70%). 
• Spin down cell debris at 4°C 10min at 13000rpm. 
• Equilibrate 150µl Glutathione Sepharose™ 4B beads (GE Healthcare) per ml cell lysate 
in TpG buffer. 
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• Add 150μl 50% glutathione sepharose beads to 1ml cell lysate.  
• Incubate overnight on a rotation mixer. 
• Centrifuge at 2000rpm 2min at 4°C and wash beads three times with TpG buffer. 
• Elute GST fusion-protein by shaking beads 10min at room temperature in 125μl elution 
buffer. 
• Spin down beads 2min at 2000rpm and repeat elution twice. 
• Repeat elution with 40mM glutathione. 
• Run 0.25 OD600 equivalents of each step on SDS-PAGE gel. 
• Stain with Coomassie Blue. 
 
TpG buffer: 20mM  Tris-HCl pH 8 
100mM  NaCl 
1mM  EDTA 
0.1mM  ZnCl2 
0.5%  NP40 (v/v) 
 
Elution buffer: 50mM  Tris-HCl pH 8 
5mM  Reduced glutathione 
 
2.4.6. Inclusion Body Preparation 
• Dilute overnight culture in 200ml LB+Amp to OD600=0.5. 
• Incubate for 60min at 30°C to equilibrate. 
• Induce protein expression by adding IPTG to a final concentration of 0.2-1mM. 
• Incubate at 30°C for 4h. 
• Harvest cells at 5000rpm 10min in a Sorvall centrifuge (GS3 rotor). 
• Resuspend pellet in 10ml lysis buffer. 
• Add 1ml freshly made lysozyme (20mg/ml stock solution) at a final concentration of 
1mg/ml. 
• Leave on ice for 60min. 
• Add directly to the suspension from stocks: 
300µl 10% NP-40 (final 0.1%) 
200µl DNaseI (Fermentas) 
300µl 1M MgCl2 (final 10mM) 
adjust volume to 30ml with Lysis Buffer. 
• Mix thoroughly with a glass pipette. 
• Leave on ice for at least 60min. 
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• Lyse remaining cells by sonicating 3 times for 15 imp, cycle 70% (sonicator: Bandelin 
electronics, UW70, tip SH70). 
• Spin down 10min at 7000rpm 4°C (Sorvall HB4), pellet should be whitish (complete 
lysis). 
• Wash IB by resuspending pellet in 30ml Lysis Buffer + 1% NP-40 detergent. 
• Wash IB by resuspending pellet in 30ml Lysis Buffer + 2M Urea. 
• Wash IB by resuspending pellet in 30ml Lysis Buffer and respinning. 
• Repeat washing steps until the pellet loses all the brownish color and is completely 
white/grey. 
• Resuspend pellet in approximately 4ml Lysis Buffer and freeze in 1ml aliquots. 
• Run 0.15 OD600 equivalents on SDS-PAGE gel. 
• Stain with Coomassie Blue. 
 
Lysis buffer: 50mM  Tris-HCl pH 7.8 
100mM  NaCl 
10mM  EDTA 
 
2.4.7. Rabbit Antibody Production 
New Zealand White Rabbits (Charles River Canada) were injected with the indicated 
amount of purified antigen (2µg/ml in PBS) (Table 3). Rabbit #129 was injected with GST-
Hat1 and rabbit #128 was injected with GST-Hat2. Blood was drawn at the indicated time 
points to test for antibody specificity. 
 
Table 3: Antibody production schedule. 
day amount antigen  
0  preimmune 
6 400µg 1st injection 
28 250µg 2nd injection 
49  1st bleed 
53 125µg 3rd injection 
67  2nd bleed 
75 125µg 4th injection 
90  3rd bleed 
96 125µg 5th injection 
103  4th bleed 
110  5th bleed 
126  6th bleed 
131  final bleed 
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Testing of antiserum: 
• Leave blood at room temperature for several hours to coagulate. 
• Spin down 20min at 4000rpm 4°C. 
• Add NaN3 to the supernatant at a final concentration of 0.02%. 
• Sterile filter through a 0.45µm filter. 
• Test different dilutions of the antiserum in a Western blot. 
 
2.4.8. IgG Purification with Ammonium Sulfate 
• Centrifuge serum for 20-30min at 10000g 4°C. 
• Transfer supernatant to a fresh tube and add saturated ammonium sulfate solution 
dropwise to produce 35-45% final saturation. 
• Incubate on rotation shaker at 4°C overnight. 
• Spin down 2min at 13000rpm 4°C. 
• Discard the supernatant and dissolve the precipitate in 10-20% of the original volume in 
PBS. 
• Load on Amicon Ultra 10k (Millipore) for buffer exchange to PBS. 
 
2.4.9. Affinity Purification of Polyclonal Antibodies 
• Spot 100µg Hat1-GST onto nitrocellulose membrane and let dry. 
• Place membrane in 15ml tube. 
• Block membrane with 5% milk in PBS for 1h at room temperature. 
• Wash three times with PBS-T for 5min. 
• Incubate with 5ml antiserum overnight at 4°C. 
• Remove depleted fraction and store (→ control). 
• Wash three times with PBS-T for 5min. 
• Elute with 5ml 100mM glycine-HCl pH 2.5 for 2, 5, 10 and 15min. 
• Remove liquid and immediately adjust to pH 7 by adding 0.1ml 1M Tris-HCl pH 8 per ml 
glycine. 
• Load on Amicon Ultra 10k (Millipore) for buffer exchange to PBS. 
• Add NaN3 at a final concentration of 0.02% and store at 4°C. 
• Store membrane in PBS with 0.02% NaN3 – can be reused. 
 
PBS-T: 1x PBS 
0.1% Tween-20 
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2.4.10. Immunoprecipitation 
• Dilute overnight culture in 100ml YPD to an OD600 of 0.3. 
• Grow at 30°C to an OD600 of ~2.0. 
• Harvest cells by centrifugation for 5min at 3000rpm 4°C. 
• Wash cells with 20ml cold H2O, centrifuge again. 
• Resuspend cells in breaking buffer (Buffer A or PBS) (250µl Buffer/50 OD units), 
transfer 50 OD600 units to 2ml screw cap tubes and add equal volume glass beads. 
• Break up cells with FastPrep (FastPrep®-24, MP Biomedicals), 5x 30sec at 6m/sec with 
5min on ice between the runs. 
• Spin down beads and cell debris for 5min at 13000rpm and 4°C and pool supernatants. 
• Spin supernatant again for 15min at 13000rpm and 4°C. 
• Determine protein concentration by measuring absorption at 280nm (1:200 dilution). 
• Add 2µg antibody to the supernatant and incubate o/n at 4°C on a rotary shaker. 
• Prepare 50µl Dynabeads® Protein G (Invitrogen) according to the manual (Step 2.1). 
• Resuspend beads in 50µl breaking buffer (Buffer A or PBS) and add to the extract. 
• Incubate for 4h at 4°C. 
• Wash the beads three times using 200µl breaking buffer. 
• Resuspend beads in 100µl breaking buffer and transfer to a new tube. 
• Place tubes on the magnet, remove the supernatant and resuspend in 20µl 2x Lämmli 
buffer. 
• Incubate at 70°C for 10min and run SDS-PAGE. 
 
Buffer A:  50mM  HEPES pH 8 
400mM  (NH4)2SO4 
5%  Glycerol (v/v) 
0.5mM  EDTA 
protease inhibitor cocktail, EDTA-free (Roche) 
 
2x Lämmli Buffer: 0.125M  Tris-HCl pH 6.8 
4%  SDS 
10%  β-mercaptoethanol (freshly added) 
20%  Glycerol 
0.004%  Bromophenol blue 
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2.4.11. Determination of Protein Concentration – Bradford Method 
• Prepare BSA standard solutions (25, 125, 250, 500, 750, 1000, 1500, 2000µg/ml). 
• Add 35µl sample to 1ml Bio-Rad Protein Assay Dye Reagent Concentrate, vortex-mix. 
• Let stand for 10min at room temperature. 
• Measure absorbance at 595nm. 
• Draw standard curve and calculate protein concentrations of samples from the graph. 
 
2.4.12. Determination of Protein Concentration – BCA Assay 
• Prepare BSA standard solutions (25, 125, 250, 500, 750, 1000, 1500, 2000µg/ml). 
• Add 25µl sample and 25µl 10%SDS to 1ml BCA reagent (bicinchoninic acid (Sigma) 
containing 0.08% CuSO4) and vortex-mix. 
• Incubate 30min at 37°C. 
• Measure absorbance at 562nm. 
• Draw standard curve and calculate protein concentrations of samples from the graph. 
 
2.5. Oligonucleotides, Strains, Plasmids and Antibodies 
2.5.1. Oligonucleotides 
Name Sequence 5’ – 3’ 
HAT1-antig2_fwd ATCGGATCCCCGGAGCGGGTGATGATAACACCAAGAAAG 
HAT1-antig2_rev ATCGAATTCGCTAATAATACAAATATACTTAC 
HAT2-antig2_fwd ATCGGATCCCCGGAGCGGGTGGAGTGAGTGATTTAAGTTG 
HAT2-antig2_rev ATCGAATTCTAGGGCCAGTTTTACTC 
SATflipp_5C TTTGGAACTAACGATGCATACGAC 
SATflipp_3C CCTAACATATGTGAAGTGTGAAGGG 
heukan2 CGTCAAGACTGTCAAGGAGGG 
heukan3 CATCATCTGCCCAGATGCGAAG 
5C_HAT2_FPTag GACACTGAAACCAGGTACTCAC 
55_CA2146_FPTag GTCAGAGGATAGTCATGTCTACTTG 
53_HAT2-FPTag CTTCACCTTTAGAACCTGCGGCCTCTAAAATCGACACATCTACTTC 
35_HAT2-pFA GCTGCTGCAGGTCGACCGGTGTCGGAACTGGCCCTAGCTAGAG 
35_HAT2-pSFS GCGCTTGGCGTAATCATGGAACTGGCCCTAGCTAGAG 
33_Ca2146 ATCGGAGCTCTCGAGCGATCGCCTAGTCTAAATGTTTAGCTGTGTGG 
55_2_Ca2146_FPTag AATACTATGCCGAGTCCTCC 
33_2_Ca2146 CCAATACCAAACCACAAAGCC 
FPoe_fwd GCCGCAGGTTCTAAAGGTGAAGAATTATTCAC 
pFA6a-backb_rev CCGACACCGGTCGACCTGCAGCAGCAGGTTAACCTGGCTTATCG 
SATflipp_oe_rev CCATGATTACGCCAAGCGC 
YEPoe_rev CCGGGCTCTAGAACTAGTGGATC 
FP_KpnISmaI_fwd ATGCCCGGGTACCATGTCTAAAGGTGAAGAATTATTCAC 
FP_AscI_rev ATCGGCGCGCCTTATTTGTACAATTCATCCATACCATG 
FPTag_5C GCATCACCTTCACCTTCACC 
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Name Sequence 5’ – 3’ 
RFP_KpnISmaI_fwd ATCGGTACCCGGGATGGATAACACTGAAGATGTTATTAAAG 
RFP_ApaIAscI_rev ATCGGGCCCGGCGCGCCTTATTGAGAACCAGAGTGTCTAG 
55_Ca2146_XmaI_RFP ACTCCCGGGTCAGAGGATAGTCATGTCTACTTG 
53_Ca2146_XmaI_RFP ACTCCCGGGAGCACCCTCTAAAATCGACACATCTACTTCAG 
53_CaHAT2oe_mCherry CTTCTTCACCTTTTGAAACACCTGCGGCCTCTAAAATCGACACATCTACTTC
RFPoe_ATG_fwd GCCGCAGGTATGGATAACACTGAAGATGTTATTAAAG 
RFPoe_fwd GCCGCAGGTGATAACACTGAAGATGTTATTAAAGAATTC 
RFP_5C_rev TTGAGTACCTTCATATGGTTTACC 
mCherry_KpnISmaI_fwd ATCGGTACCCGGGATGGTTTCAAAAGGTGAAGAAG 
mCherry_ApaIAscI_rev ATCGGGCCCGGCGCGCCTTATTTATATAATTCATCCATACCACC 
mCherry_ATG_fwd ATGGTTTCAAAAGGTGAAGAAG 
mCherry_oe_fwd GCCGCAGGTGTTTCAAAAGGTGAAGAAGATAATATGG 
mCherry_5C_rev GAGTACCTTCATATGGTCTACCTTC 
5C_CaACT1 GAAGCAAGTATATCTGGCAAAC 
55_CaACT1 CAGTACAACGAATATTTCAGCG 
53_CaACT1oe_RFP CATCTTCAGTGTTATCCATACCTGCGGCTACCACCGTCCATTTTGAATG 
53_CaACT1oe_mCherry CTTCACCTTTTGAAACCATTTTGAATGATTATATTTTTTTAATATTAATATCG 
35_CaACT1oe GCTGCAGGTCGACCGGTGTCGGGAGTGAAATTCTGGAAATCTGG 
33_CaACT1 CATAAAACAACGAGATTTACTAATACAAG 
3C_CaACT1 CAACAACAACAATTTCAATCCATC 
5C_Ca2146 TTACATTCACCAACTGCAGTGACC 
55_Ca2146 ACGTGGGCCCGATCGGAAACGAAGCCGAGACATAGGC 
53_Ca2146 ATCGCTCGAGGGCTGGTGTTGAAAAGAAAAAGTGAC 
35_Ca2146 ACGTCCGCGGTAAAACTGGCCCTAGCTAGAGAC 
33_Ca2146 ATCGGAGCTCTCGAGCGATCGCCTAGTCTAAATGTTTAGCTGTGTGG 
3C_Ca2146 GTTTTGGCTGTAAGTGACAAGTGC 
INT5_Ca2146 GTACGGTCTTTCATGGAACCC 
INT3_Ca2146 TCGGCATAGTATTGGCTAACC 
5c_ASF1 CCATTTTAAACTAGCAATAACCAAG 
55_ASF1_KpnI  CATGGTACCTAAAACCGCACTATCTACCG 
53_ASF1_ApaI_rev TCAGGGCCCATGGAGTTTGGGTCTTGAG 
35_ASF1_BglII AGTAGATCTCCAAAAGACTAGCTAAACATAAC 
33_ASF1_NotIApaI_rev ATCGGGCCCGCGGCCGCGAATTTGCTGAGAGATGATGATAATC 
3c_ASF1_rev  TGGGGACGAAGATGATGATG 
INT5_ASF1 CCTGCTAGTGAATTAGTTAGTGTC 
INT3_ASF1 TCATCTTCATCTTCTTCCTCCTC 
ASF1_oe_fwd AAATACCCTCCCCAGAAAACATGTCGATAGTATCATTAACAGGAATTG 
ASF1_AscI_rev ATCGGCGCGCCTCTACTTCACTTTCACTAGC 
MET3-P_SmaI_fwd AGTCCCGGGAATGACTATTGGTAGCGTGTTC 
MET3-P_oe_rev GTTAATGATACTATCGACATGTTTTCTGGGGAGGGTATTTAC 
ASF1_2_AscI_rev ATCGGCGCGCCGAACAACTTAATATTATCACGGTGAC 
ASF1_int_fwd ATTAGATCATGATCAAGAATTAGATAG 
ASF1_int_rev GAATCTGATGATCCAACATAAG 
ur_ASF1_fwd ACTGGTACCTGATATACCATTAGTTATACTATGC 
ur_ASF1_rev ACTGGTACCACTCACATTTCAGTACCATATC 
MET3-P_KpnI_fwd ACTGGTACCAATGACTATTGGTAGCGTGTTC 
5C_ur_ASF1_fwd ATAATGTGCTCCAACGAGTATTC 
MET3-P_5C_rev GCTTGGAATAGACAATTGTTCG 
5c_RTT109 TTTAAGTTTATAGGTGGTGTATTTGG 
55_RTT109_KpnI CATGGTACCATCCCAGTTAATTGTTTACCATCTG 
53_RTT109_ApaI_rev TCAGGGCCCTAAAACAACAAGATCTTGATGTAG 
35_RTT109_BglII  AGTAGATCTATCGACGATAACCTCACAC 
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Name Sequence 5’ – 3’ 
33_RTT109_NotIApaI_rev ATCGGGCCCGCGGCCGCGTTATCTTGCAGCATGATAG 
3c_RTT109_rev CTAGAAGTTGTAGTCTCTTGTGATG 
INT5_RTT109 GCATTGAGTACCGAACTTTACC 
INT3_RTT109 CGACACTCTACAATTACCAATTCC 
5C_CaHHF1 GTATTGTTTTGTTTGTGCCTGG 
55_CaHHF1 ATCCGATCGGTACCCTCTTTTATTCTTCCCCATC 
53_CaHHF1 ATCGGGCCCGATTAATTGATTTATTTGTAGATG 
35_CaHHF1 ATCAGATCTACTGGGTTGTATTTCTAATTGTC 
33_CaHHF1 ATCGGGCCCGCGGCCGCAAACTCAGTGAGCTGTTACG 
3C_CaHHF1 CCTCCATCAATTGCTTCAAACC 
5C_CaHHF22 CGTCTTTCTCTCTCTTGTGTAC 
55_CaHHF22 ATCGGTACCCCAAGATGAGAATAGATGGAAC 
53_CaHHF22 ATCGGGCCCAAAGGAGAATATTAAAGCTTCAATG 
35_CaHHF22 ATCAGATCTCTTCTTTTCTTTATGTTTTTCGATTC 
33_CaHHF22 ATCGCGGCCGCTTTTCAGGCTACTTCAAAGG 
33_CaHHF22_ApaINotI ATCGGGCCCGCGGCCGCTTTTCAGGCTACTTCAAAGG 
3C_CaHHF22 CTCAAAGTCATACAGTCAAGCTAAC 
5C_CaHHT2 TCTTCCCTTGAATATGCCCAG 
55_CaHHT2 ATCCGATCGGTACCCCATCATACATCATCCATGC 
53_CaHHT2 ATCGGGCCCTCTTAGGTTTTATTTCCTTGATGG 
INT5_HHT2 CAACAGTACCTGGCTTATATCTG 
INT3_HHT2 CGTTCCATCTATTCTCATCTTGG 
HHF1 K5Q_fwd GGTACCGGTAGAGGACAAGGTGGTAAAGGTTT 
HHF1 K5Q_rev AAACCTTTACCACCTTGTCCTCTACCGGTACC 
HHF1 K5R_fwd GGTACCGGTAGAGGAAGAGGTGGTAAAGGTTT 
HHF1 K5R_rev AAACCTTTACCACCTCTTCCTCTACCGGTACC 
HHF1 K12Q_fwd GGTAAAGGTTTAGGACAAGGTGGTGCTAAACG 
HHF1 K12Q_rev CGTTTAGCACCACCTTGTCCTAAACCTTTACC 
HHF1 K12R_fwd GGTAAAGGTTTAGGAAGAGGTGGTGCTAAACG 
HHF1 K12R_rev CGTTTAGCACCACCTCTTCCTAAACCTTTACC 
RT5_CaH4 GAGGTGGTGTTAAACGTATTTCTG 
RT3_CaH4 CAACATCCAATGAAGTGACGG 
RT5_CaASF1 TGAATATCCTCCTGAACAACCA 
RT3_CaASF1 ATCACCATTAAGGTCTTCATCGTC 
RT5_CaMET3 CTATGAGAATGGGTGGTGATAGAG 
RT3_CaMET3 GGACCATAGAAATCCACTCCT 
 
2.5.2. Bacterial Strains 
Name Genotype Source 
DH5α F
- φ80lacZ∆M15 ∆(lacZYA-argF)U169 recA1 endA1 
hsdR17(rk-, mk+) phoA supE44 thi-1 gyrA96 relA1 λ- 
Invitrogen 
TOP10 
F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacΧ74 
recA1 araD139 ∆(ara-leu) 7697 galU galK rpsL (StrR) endA1 
nupG λ- 
Invitrogen 
BL21 (DE3) F- ompT hsdSB (rB-, mB-) gal dcm rne131 Invitrogen 
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2.5.3. Candida albicans Strains 
Name Genotype Parent strain 
SC5314 clinical isolate  
MT007 hat1∆::FRT/HAT1  
MT014 hat1∆::FRT/hat1∆::FRT  
MT031 hat2∆::FRT/HAT2  
MT039 hat2∆::FRT/hat2∆::FRT  
MT088 hat1∆::FRT/hat1∆::FRT hat2∆::FRT/HAT2  
CaES002 asf1∆::FRT/ASF1 SC5314 
CaES079 asf1∆::PMET3-ASF1-FRT/ASF1 CaES002 
CaES004 rtt109∆::FRT/RTT109 SC5314 
CaES008 rtt109∆::FRT/rtt109∆::FRT CaES004 
CaES024 rtt109∆::FRT/rtt109∆::RTT109 CaES008 
CaES068 hat1∆::FRT/hat1∆::FRT rtt109∆::FRT/RTT109 MT014 
CaES070 hat1∆::FRT/HAT1 rtt109∆::FRT/rtt109∆::FRT CaES008 
CaES076 hat1∆::FRT/hat1∆::FRT rtt109∆::FRT/rtt109∆::FRT CaES070 
CaES005 HAT2-YFP-NAT1/ hat2∆::FRT MT031 
CaES012 hat1∆::FRT/hat1∆::FRT HAT2-YFP-NAT1/HAT2 MT014 
CaES031 hat1∆::FRT/hat1∆::FRT hat2∆/HAT2-YFP-FRT MT088 
CaES037 hat1∆::FRT/hat1∆::HAT1-FRT hat2∆/HAT2-YFP CaES031 
CaES039 hat1∆::FRT/HAT1 hat2∆::FRT/HAT2 MT007 
CaES016 hhf1∆::FRT/HHF1 SC5314 
CaES020 hhf1∆::FRT/hhf1∆::FRT CaES016 
CaES030 hhf1∆::FRT/hhf1∆::FRT hhf22∆::FRT/HHF22 CaES028 
CaES116 hhf1∆::FRT/HHF1 hht2-hhf22∆::FRT/HHT2-HHF22 CaES016 
CaES050 hhf1∆::FRT/hhf1∆::HHF1 hhf22∆::FRT/HHF22 CaES030 
CaES065 hhf1∆::FRT/hhf1∆::HHF1 hhf22∆::FRT/HHF22 CaES030 
CaES096 hhf1∆::FRT/hhf1∆::HHF1 hhf22∆::FRT/HHF22 CaES030 
CaES097 hhf1∆::FRT/hhf1∆::HHF1 hhf22∆::FRT/HHF22 CaES030 
CaES045 hhf1∆::FRT/hhf1∆::HHF1 K12Q hhf22∆::FRT/HHF22 CaES030 
CaES063 hhf1∆::FRT/hhf1∆::HHF1 K12Q hhf22∆::FRT/HHF22 CaES030 
CaES092 hhf1∆::FRT/hhf1∆::HHF1 K12Q hhf22∆::FRT/HHF22 CaES030 
CaES047 hhf1∆::FRT/hhf1∆::HHF1 K12R hhf22∆::FRT/HHF22 CaES030 
CaES048 hhf1∆::FRT/hhf1∆::HHF1 K12R hhf22∆::FRT/HHF22 CaES030 
CaES064 hhf1∆::FRT/hhf1∆::HHF1 K12R hhf22∆::FRT/HHF22 CaES030 
CaES093 hhf1∆::FRT/hhf1∆::HHF1 K12R hhf22∆::FRT/HHF22 CaES030 
CaES094 hhf1∆::FRT/hhf1∆::HHF1 K12R hhf22∆::FRT/HHF22 CaES030 
CaES095 hhf1∆::FRT/hhf1∆::HHF1 K12R hhf22∆::FRT/HHF22 CaES030 
CaES083 hhf1∆::FRT/HHF1 hat1∆::FRT/hat1∆::FRT MT014 
CaES107 HHF1/hhf1∆::HHF1-FRT hat1∆::FRT/hat1∆::FRT CaES083 
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Name Genotype Parent strain 
CaES108 HHF1/hhf1∆::HHF1-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES143 HHF1/hhf1∆::HHF1 K5Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES144 HHF1/hhf1∆::HHF1 K5Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES145 HHF1/hhf1∆::HHF1 K5Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES146 HHF1/hhf1∆::HHF1 K5Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES147 hhf1∆/hhf1∆::HHF1 K5Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES148 hhf1∆/hhf1∆::HHF1 K5Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES149 hhf1∆/hhf1∆::HHF1 K5Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES150 hhf1∆/hhf1∆::HHF1 K5Q K12Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES151 hhf1∆/hhf1∆::HHF1 K5Q K12Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES105 HHF1/hhf1∆::HHF1 K12Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES106 HHF1/hhf1∆::HHF1 K12Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES109 hhf1∆/hhf1∆::HHF1 K12Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES152 hhf1∆/hhf1∆::HHF1 K12Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES153 hhf1∆/hhf1∆::HHF1 K12Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES154 hhf1∆/hhf1∆::HHF1 K12Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES155 hhf1∆/hhf1∆::HHF1 K12Q-FRT hat1∆::FRT/hat1∆::FRT CaES083 
CaES072 hat1∆::FRT/HAT1 hhf1∆/∆::HHF1 K12Q hhf22∆::FRT/HHF22 CaES045 
 
2.5.4. Plasmids 
Name DNA-insert  (nucleotide position) 
Parental plasmid / 
reference 
pGEX-5X-2 (gb_U13857)  GE Healthcare 
pGEX-5X-2_Hat1 Antigen HAT1 (+4 to +243) pGEX-5X-2 
pGEX-5X-2_Hat2 Antigen HAT1 (+4 to +156) pGEX-5X-2 
pGEX-5X-2_Hat1 Antigen2 HAT2 (+1093 to +1261) pGEX-5X-2 
pGEX-5X-2_Hat2 Antigen2 HAT2 (+1006 to +1161) pGEX-5X-2 
YEp352-GFP  Ingrid Frohner 
YEp352-CFP  Ingrid Frohner 
YEp352-YFP  Ingrid Frohner 
pSFS3b  Michael Tscherner 
pSFS3b-GFP GFP pSFS3b 
pSFS3b-YFP YFP pSFS3b 
pSFS3b-CFP CFP pSFS3b 
pFA6a-GFP  Michael Tscherner 
pFA6a-YFP YFP pFA6a-GFP 
pFA6a-CFP CFP pFA6a-GFP 
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Name DNA-insert  (nucleotide position) 
Parental plasmid / 
reference 
pMG2169-RFP-URA3  FGSC (Gerami-Nejad et al., 2009) 
pFA6a-RFP RFP pFA6a 
pSFS3b-RFP RFP pSFS3b 
pMG2254-mCherry-URA3  FGSC (Gerami-Nejad et al., 2009) 
pFA6a-mCherry mCherry pFA6a 
pSFS3b-mCherry mCherry pSFS3b 
pSFS3b-3'HAT2_RFP downstream region HAT2 pSFS3b-RFP 
pSFS3b-HAT2_RFP HAT2 (+615 to +1146) pSFS3b-HAT2_RFP 
pSFS3b-3'ASF1 downstream region ASF1 pSFS3b 
pSFS3b-ASF1 urdr upstream region ASF1 pSFS3b-3'ASF1 
pFA6a-MET3-P_ASF1 PMET3-ASF1 (+1 to +697) pFA6a 
pFA6a-MET3-P_ASF1_2 PMET3-ASF1 (+1 to +299) pFA6a 
pSFS3b-MET3P-ASF1-drASF1 PMET3-ASF1 (+1 to +1235) pSFS3b-3'ASF1 
pSFS3b-urASF1-MET3P-ASF1-
drASF1 upstream region PASF1 
pSFS3b-MET3P-ASF1-
drASF1 
pSFS3b-3'RTT109 downstream region RTT109 pSFS3b 
pSFS3b-RTT109 urdr upstream region RTT109 pSFS3b-3'RTT109 
pSFS3b-CaRTT109-Rev RTT109 (-348 to +1653) pSFS3b-3'RTT109 
pSFS3b-3'HHF1 downstream region HHF1 pSFS3b 
pSFS3b-HHF1 urdr upstream region HHF1 pSFS3b-3'HHF1 
pSFS3b-CaHHF1-Rev HHF1 (-521 to +803) pSFS3b-3'HHF1 
pSFS3b-CaHHF1 K5Q HHF1 K5Q pSFS3b-CaHHF1-Rev 
pSFS3b-CaHHF1 K5Q K12Q HHF1 K5Q K12Q pSFS3b-CaHHF1 K12Q 
pSFS3b-CaHHF1 K12Q HHF1 K12Q pSFS3b-CaHHF1-Rev 
pSFS3b-CaHHF1 K12R HHF1 K12R pSFS3b-CaHHF1-Rev 
pSFS3b-3'HHF22 downstream region HHF22 pSFS3b 
pSFS3b-HHF22 urdr upstream region HHF22 pSFS3b-3'HHF22 
pSFS3b-5'HHT2-3'HHF22 upstream region HHT2 pSFS3b-3'HHF22 
 
2.5.5. Antibodies 
Antibody Dilution Type Source 
α-H4 1:1000 rabbit, polyclonal Abcam, ab10158 
α-H4K12 1:3000 rabbit, polyclonal Upstate, cat.#: 07-595 
α-H3 1:1000 rabbit, polyclonal Abcam, ab46765 
α-GFP 1:1000 mouse, mixture of 2 monoclonal ab Roche, cat.#: 11814460001 
α-RFP 1:1000 rabbit, polyclonal BioVision, cat.#: 3993-100 
α-Hat1 1:500 rabbit, polyclonal rabbit #129 
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Antibody Dilution Type Source 
α-Hat2 1:4000 rabbit, polyclonal rabbit #128 
α-rabbit IRDye 800CW 1:14000 goat LI-COR, cat.#: 926-32211 
α-rabbit IRDye 680 1:14000 goat LI-COR, cat.#: 926-32221 
α-mouse IRDye 800CW 1:14000 goat LI-COR, cat.#: 926-32210 
α-mouse IRDye 680 1:14000 goat LI-COR, cat.#: 926-32220 
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3. Results 
3.1. α-Hat1 and α-Hat2 Antibodies 
 
Polyclonal antibodies against CaHat1 and CaHat2 should be raised to obtain a tool for 
further characterization of the function of these two proteins in Candida albicans. The 
antibodies should allow the determination of protein levels via immunoblotting. 
Furthermore, they should be used in immunoprecipitation experiments to identify binding 
partners of CaHat1 and CaHat2. 
 
3.1.1. N-terminal Antigen 
The first step for raising antibodies against CaHat1 and CaHat2 was to select antigenic 
regions for both proteins, which were then used for immunization of two rabbits. The 
plasmids pGEX-5X-2_Hat1-Antigen and pGEX-5X-2_Hat2-Antigen (Figure 8) were 
constructed by Michael Tscherner for this purpose. The N-terminal regions of Hat1 and 
Hat2 were chosen (amino acids 2 – 81 and 2 – 52 respectively). The sequence was PCR-
amplified from genomic DNA and cloned into the pGEX-5X-2 vector. pGEX-5X-2 contains 
the glutathione-S-transferase ORF after the Ptac promoter. This promoter is repressed by 
LacI which can be inactivated by addition of IPTG. The antigenic regions of Hat1 and Hat2 
were cloned into pGEX-5X-2 in frame with GST to create a GST-Hat1 and GST-Hat2 fusion 
protein, respectively.  
 
Figure 8: Plasmids to express the N-terminal antigen of Hat1 and Hat2. The N-terminal part of 
the coding sequence of Hat1 and Hat2 was cloned in frame after GST into pGEX-5X-2. 
 
The expression of GST-Hat1 in bacterial DH5α cells after induction with IPTG was 
examined as described in section 2.4.5. Expression was induced by addition of IPTG to a 
final concentration of 0.2mM. Aliquots were taken at several time points to determine the 
optimal induction time. Furthermore, 0.32 OD600 equivalents were separated trough a 12% 
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SDS-PAGE gel and stained with Coomassie Blue. Hardly any expression could be 
detected. Thus, the experiment was repeated with a final concentration of 1mM IPTG. This 
time 0.2 OD600 equivalents taken from several time points were separated through a 12% 
SDS-PAGE gel and stained with Coomassie Blue. Since expression levels were still 
relatively low, even after induction with 1mM IPTG and incubation for 4 hours, pGEX-5X-
2_Hat1-Antigen, as well as pGEX-5X-2_Hat2-Antigen were transformed into protease 
deficient BL21 (DE3) cells. Expression of GST-Hat1 and GST-Hat2 in BL21 cells was 
examined after induction with 1mM, 5mM and 10mM IPTG for 3 hours. Again, 0.2 OD600 
equivalents were separated through a 12% SDS-PAGE gel and stained with Coomassie 
Blue. A concentration of 1mM IPTG was found to be sufficient to induce expression of GST-
Hat1 and GST-Hat2 (Figure 9).  
 
Figure 9: Induction of GST-Hat1 and GST-Hat2 expression. BL21 cells harboring pGEX-5X-2 (V), 
pGEX-5X-2_Hat1-Antigen or pGEX-5X-2_Hat2-Antigen were induced to express the GST-fusion 
proteins (GST 27.5kDa, GST-Hat1 36.2kDa, GST-Hat2 33.3kDa) by addition of 1mM, 5mM and 
10mM IPTG and incubated at 30°C for 180 minutes. 0.2 OD600 equivalents before (0’) and after 
(180’) induction were separated through a 12% SDS-PAGE gel and stained with Coomassie Blue. 
 
The next step was to determine the solubility of the GST-Hat1 and GST-Hat2 fusion 
proteins. Solubility was tested as described in section 2.4.5. Expression of the fusion 
proteins was induced by addition of IPTG to a final concentration of 1mM. Cells were grown 
at 30°C for 3 hours before they were lysed by sonication. The soluble fraction was 
separated from the insoluble fraction by centrifugation. Aliquots of total extracts, the 
insoluble fractions and the soluble fractions were separated through a 12% SDS-PAGE gel 
and stained with Coomassie Blue. Unfortunately the majority of the fusion proteins were 
detected in the insoluble fractions, which are so-called inclusion bodies (Figure 10).  
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Figure 10: Solubility of GST-Hat1 and GST-Hat2. BL21 cells harboring pGEX-5X-2, pGEX-5X-
2_Hat1-Antigen or pGEX-5X-2_Hat2-Antigen were induced to express the GST-fusion proteins (GST 
27.5kDa, GST-Hat1 36.2kDa, GST-Hat2 33.3kDa) by addition of 1mM IPTG and incubated at 30°C 
for 180 minutes. 0.2 OD600 equivalents of total extracts, 0.5 OD600 equivalents of the insoluble 
fraction and 8µl of the soluble fraction were separated through a 12% SDS-PAGE gel and stained 
with Coomassie Blue. 
 
To increase the solubility of fusion proteins, bacterial cells were grown at a lower 
temperature. First, induction with 1mM IPTG at 25°C was checked. Aliquots were taken at 
several time points and 0.2 OD600 equivalents were separated through a 12% SDS-PAGE 
gel and stained with Coomassie Blue. Even though the expression was not very strong, 
solubility of GST-Hat1 was tested. Expression was induced with 1mM IPTG and cells were 
grown at 25°C for 2 hours. Cells were lysed by sonication. Soluble and insoluble fractions 
were separated by centrifugation. Aliquots of total extracts, the insoluble fraction and the 
soluble fraction were separated through a 12% SDS-PAGE gel and stained with Coomassie 
Blue. Still the majority of GST-Hat1 was found in the insoluble fraction (Figure 11). 
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Figure 11: Solubility of GST-Hat1 at 25°C. BL21 cells harboring pGEX-5X-2 or pGEX-5X-2_Hat1-
Antigen were induced to express the GST-fusion protein (GST 27.5kDa, GST-Hat1 36.2kDa) by 
addition of 1mM IPTG and incubated at 25°C for 120 minutes. 0.2 OD600 equivalents of total extracts, 
0.5 OD600 equivalents of the insoluble fraction and 8µl of the soluble fraction were separated through 
a 12% SDS-PAGE gel and stained with Coomassie Blue. 
 
To purify the antigen from the insoluble fraction, inclusion bodies were prepared as 
described in section 2.4.6. Expression of the fusion proteins was induced with 1mM IPTG. 
Cells were grown at 30°C for 4 hours. Cells were lysed using lysozyme and sonication. The 
insoluble fraction was washed with different buffers to obtain a cleaner inclusion body 
pellet. Samples were taken at every step and were separated through a 12% SDS-PAGE 
gel. Coomassie Blue-staining revealed that there were still other proteins, as well as 
degraded fusion proteins present in the inclusion bodies (Figure 12).  
 
Figure 12: Inclusion body preparation of GST-Hat1 and GST-Hat2. BL21 cells harboring pGEX-
5X-2 or pGEX-5X-2_Hat1-Antigen were induced to express the GST-fusion proteins (GST-Hat1 
36.2kDa, GST-Hat2 33.3kDa) by addition of 1mM IPTG and incubated at 30°C for 240 minutes. Cells 
were lysed by lysozyme treatment and sonication (Lysis). Soluble (SN1) and insoluble fractions (P1) 
were separated by centrifugation. The pellet was washed with lysis buffer + 1% NP-40 (SN2, P2), 
lysis buffer + 2M urea (SN3, P3) and finally with only lysis buffer (SN4, P4). 0.15 OD600 equivalents 
were separated through a 12% SDS-PAGE gel and stained with Coomassie Blue. 
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3.1.2. C-terminal Antigen 
Since the fusion protein of GST with the N-terminal region of Hat1 and Hat2 did not 
produce a soluble protein, a second antigenic region was chosen. This time the C-terminal 
region of Hat1 and Hat2 was used. Amino acids 365 to 413 of Hat1 and 363 to 382 of Hat2 
were selected. These regions were PCR-amplified using primers HAT1-antig2_fwd and 
HAT1-antig2_rev for Hat1 and HAT2-antig2_fwd and HAT2-antig2_rev for Hat2. The 
fragments were cloned in frame with GST into pGEX-5X-2 with BamHI and EcoRI resulting 
in the plasmids pGEX-5X-2_Hat1-Antigen2 and pGEX-5X-2_Hat2-Antigen2 (Figure 13).  
 
Figure 13: Plasmids to express the C-terminal antigen of Hat1 and Hat2. The C-terminal part of 
the coding sequence of Hat1 and Hat2 was cloned in frame after GST into pGEX-5X-2. 
 
The plasmids were transformed into BL21 cells and the induction of fusion protein 
expression with 1mM IPTG was tested. Aliquots were taken at several time points to 
determine the optimal induction time and 0.2 OD600 equivalents were separated through 
12% SDS-PAGE gel followed by staining with Coomassie Blue. An induction time of 2 
hours for GST-Hat1 and 4 hours for GST-Hat2 was found to be satisfactory and was used 
for all further experiments. 
Subsequently, the solubility of the fusion protein was tested. After induction with 1mM IPTG 
and incubation for 2 hours for GST-Hat1 and 4 hours for GST-Hat2 at 30°C cells were lysed 
by sonication. Soluble and insoluble fractions were separated by centrifugation. Aliquots of 
the insoluble fraction and the soluble fraction were separated through a 12% SDS-PAGE 
gel and stained with Coomassie Blue. A significant amount of fusion protein was found in 
the soluble fraction (Figure 14). 
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Figure 14: Solubility of GST-Hat1 Antigen 2. BL21 cells harboring pGEX-5X-2 or pGEX-5X-
2_Hat1-Antigen2 were induced to express the GST-fusion protein (GST 27.5kDa, GST-Hat1 
32.8kDa) by addition of 1mM IPTG and incubated at 30°C for 120 minutes. 0.2 OD600 equivalents of 
total extracts, 0.5 OD600 equivalents of the insoluble fraction and 8µl of the soluble fraction were 
separated through a 12% SDS-PAGE gel and stained with Coomassie Blue. 
 
Expression of the fusion proteins was repeated in a larger volume to increase the yield of 
purified fusion proteins. Purification of the GST-fusion proteins used glutathione sepharose 
beads as described in section 2.4.5. Therefore, cells were lysed by sonication. The soluble 
fraction was incubated with glutathione sepharose beads overnight. Finally, the GST-Hat1 
and GST-Hat2 fusion proteins were eluted from the sepharose beads with glutathione. 
Samples were taken at every step, separated through a 12% SDS-PAGE gel and stained 
with Coomassie Blue (Figure 15).  
 
Figure 15: Elution of Antigen. 500ml LB were inoculated with BL21 cells harboring pGEX-5X-
2_Hat1-Antigen2 or pGEX-5X-2_Hat2-Antigen2 and grown for 120 minutes for Hat1 and 240 
minutes for Hat2 at 30°C. Cells were lysed by sonication. Sepharose glutathione beads were added 
to the soluble fraction. The GST-fusion protein (GST-Hat1 32.8kDa, GST-Hat2 32.0kDa) was eluted 
from the beads using glutathione buffer. 0.25 OD600 equivalents from each step were separated 
through a 12% SDS-PAGE gel and stained with Coomassie Blue. 
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The concentration of the purified protein was determined using the BCA assay as described 
in section 2.4.12. The purification of the GST-fusion protein was repeated several times to 
yield enough antigen for immunization of the rabbits. The purified GST-fusion proteins were 
loaded on an Amicon Ultra 10k to exchange the buffer to PBS. In total, about 5mg of GST-
Hat1 antigen 2 and 4mg of GST-Hat2 antigen 2 were purified (Figure 16). 
 
Figure 16: Purified C-terminal antigen. 1µl (conc. ~2mg/ml) of the purified GST-Hat1 (lane 1, 
32.8kDa) and GST-Hat2 (lane 2, 32.0kDa) fusion protein in PBS were loaded onto a 12% SDS-
PAGE gel and separated. Lane 3, 4 and 5 show 2µg, 1µg and 0.5µg BSA, respectively. The gel was 
stained with Coomassie Blue. 
 
3.1.3. Antiserum Testing 
The purified Hat1 and Hat2 antigens were used to immunize New Zealand White rabbits. 
Before the rabbits were injected with antigen for the first time their blood was tested for 
already present antibodies reacting with Candida albicans proteins as described in section 
2.4.7. Blood was drawn and left at room temperature for several hours to coagulate and 
was then centrifuged. The cleared serum supernatant was used as the antiserum. TCA-
extracts of wild type Candida albicans strain SC5314 were prepared as described in section 
2.2.2, separated through a 12% SDS-PAGE gel and blotted onto nitrocellulose membranes 
as described in section 2.4.4. The blot was incubated with various antiserum dilutions 
overnight at 4°C. Antibodies reacting with Candida albicans proteins were detected with a 
secondary IRDye labeled antibody (Figure 17). As this pre-immune serum seemed clear at 
higher dilutions, the rabbits were injected with antigen according to the schedule described 
in section 2.4.7.  
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Figure 17: Pre-immune serum control. Wildtype TCA-extract was separated through a 12% SDS-
PAGE gel and blotted onto a nitrocellulose membrane. The blot was incubated with 1:10, 1:50, 1:250 
and 1:1000 dilutions of antiserum from rabbits #128 and #129. Reacting antibodies were detected 
with an anti-rabbit IRDye800CW labeled secondary antibody. 
 
Approximately 2 weeks after each antigen injection boosting the rabbits’ immune reaction 
their blood was drawn and tested for specific antibodies against Hat1 and Hat2, 
respectively. Antisera were prepared as described before. TCA-extracts from wild type, 
hat1∆/∆ and hat2∆/∆ strains were prepared, 0.4 OD600 equivalents were separated through 
a 12% SDS-PAGE gel and blotted onto a nitrocellulose membrane. The blot was incubated 
with several dilutions of the antiserum overnight at 4°C. Antibodies were detected with a 
secondary IRDye labeled antibody. 
Figure 18 shows that the Hat2-antiserum from the 6th and 7th bleed recognized a protein 
with the molecular mass of Hat2 in the wild type extract while this band was missing in the 
hat2∆/∆ extract. Thus, a functional Hat2-specific antibody was obtained.  
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Figure 18: Hat1 and Hat2 6th and 7th bleed. TCA-extracts of indicated strains were separated 
through a 12% SDS-PAGE gel and blotted onto a nitrocellulose membrane. The membrane was cut 
and incubated with dilutions of pre-immune serum, 6th bleed and 7th bleed. An aliquot of the 6th bleed 
was frozen at -80°C before using it for the Western blot to test stability of the antibody. Bands were 
detected using IRDye800CW labeled secondary antibody. For Hat1, a strong cross reaction at the 
same molecular mass as Hat1 (48.4kDa) was detected. Therefore, the Hat1 band was not visible. 
Hat1-GFP (75.2kDa), however, is recognized. A strong signal for Hat2 (42.9kDa) was detected, 
which is missing in the hat2∆/∆ control. 
 
The Hat1-antiserum gave a signal at approximately 48kDa which would correspond to the 
calculated mass of Hat1. Unfortunately, this signal was present in the wild type as well as in 
the hat1∆/∆ extract. To test whether the Hat1-antiserum really recognizes Hat1, a GFP-
tagged Hat1 was used as a control. This protein is about 75.2kDa and can easily be 
distinguished from the unspecific bands detected with the Hat1-antiserum. Hat1-GFP was 
recognized by the Hat1-antiserum, indicating that a functional Hat1-antibody was present in 
the antiserum. The signal at 48kDa in the hat1∆/∆ extract seems to come from another 
protein of this size which is recognized as well.  
 
3.1.4. Purification of α-Hat1-Antiserum 
Since the Hat1-antiserum also recognized another protein of the same mobility as Hat1, 
purification of the specific Hat1-antibody was necessary. In the first step, the 4th bleed was 
used for affinity purification of the antibody as described in section 2.4.9. 50µg purified 
GST-Hat1 antigen was spotted onto a membrane and incubated with 300µl antiserum 
overnight. Bound antibodies were eluted by incubating in 100mM glycine pH 2.5 for 2, 5, 10 
and 15 minutes. A blot with wildtype and hat1∆/∆ TCA-extracts was incubated with dilutions 
of the elutions overnight. Antibodies were detected with a secondary IRDye labeled 
antibody. As Figure 19 shows, in the third and fourth elution step (10min and 15min) a 
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protein of 48kDa, the size of Hat1, was recognized in the wild type but not in the hat1∆/∆ 
extracts, suggesting that a pure, Hat1-specific antibody could be obtained this way. 
 
Figure 19: Purification of Hat1-antiserum 4th bleed. 0.4 OD600 equivalents TCA-extract of wild 
type (WT) (Hat1 48.4kDa) and hat1∆/∆ strains were separated through a 12% SDS-PAGE gel and 
blotted onto a nitrocellulose membrane. The membrane was cut and incubated with 1:500 dilutions 
of antiserum, Hat1-antibody depleted antiserum and eluted Hat1-antibody after 2, 5, 10 and 15 
minutes elution. 
 
The purification was repeated with the 6th bleed. 100µg purified GST-Hat1 antigen was 
spotted on a membrane and incubated with 5ml antiserum overnight. Elution and testing 
was performed as described above. Even in the last elution step, a signal at 48kDa 
remained in the hat1∆/∆ extracts. The purification procedure was repeated with varying 
amounts of spotted antigen and antiserum, as well as different elution times. However, 
attempts to produce a pure Hat1-antibody solution from the 6th bleed failed.  
In order to purify Hat1-antibody from the 6th bleed an additional purification step was 
introduced before affinity purification. Antibody IgG precipitation was performed as 
described in section 2.4.8. Saturated ammonium sulfate solution was added to 975µl 
antiserum at a final saturation of 35% and incubated on a rotation shaker overnight. After 
centrifugation, the pellet was redisolved in PBS. The remaining salt was removed by buffer 
exchange to PBS. This antibody solution was then used for affinity purification. It was 
incubated with 50µg GST-Hat1 spotted onto a membrane. Antibodies were eluted for 5, 10, 
15 and 20 minutes. Unfortunately the Western blot revealed that even after this additional 
purification step the unspecific signal at 48kDa remained (Figure 20).  
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Figure 20: Purification of Hat1-antiserum 6th bleed. 0.4 OD600 equivalents TCA-extract of the 
wildtype (WT) (Hat1 48.4kDa), hat1∆/∆ strain and Hat1-GFP (75.2kDa) expressing strain were 
separated through a 12% SDS-PAGE gel and blotted onto a nitrocellulose membrane. The 
membrane was cut and incubated with 1:500 dilutions of antiserum aliquots taken during the 
purification of the Hat1-antiserum. 
 
The purification was repeated with the remaining 4th bleed: 450µg GST-Hat1 was spotted 
onto a membrane and incubated with 3.8ml antiserum overnight. The antibody was eluted 
for 7, 10 and 15 minutes with 100mM glycine pH 2.5. Testing by immunoblotting revealed 
the last elution step to be pure Hat1-specific antibody (Figure 21). For storage the buffer of 
this fraction was exchanged to PBS over an Amicon Ultra 10k. About 3ml of pure Hat1-
antibody solution for use in Western blots and immunoprecipitation experiments was 
obtained this way. 
 
Figure 21: Purification of remaining Hat1-antiserum 4th bleed. 0.4 OD600 equivalents TCA-extract 
of wildtype (WT) (Hat1 48.4kDa) hat1∆/∆ strain and Hat1-GFP (75.2kDa) expressing strain were 
separated through a 12% SDS-PAGE gel and blotted onto a nitrocellulose membrane. The 
membrane was cut and incubated with 1:500 dilutions of antiserum, Hat1-antibody depleted 
antiserum and eluted Hat1-antibody after 7, 10 and 15 minutes elution. 
 
Results 
58 
3.1.5. Immunoprecipitation of Hat1 and Hat2 
To investigate the interaction of Hat1 with Hat2, the raised antibodies were used to 
immunoprecipitate Hat1 and Hat2, respectively. The goal was to confirm a suspected 
interaction between Hat1 and Hat2 by co-precipitating one with the other. Furthermore, a 
possible interaction of Hat1/Hat2 with histone H4, the substrate of Hat1, should be tested. 
 
Hat2-immunoprecipitation 
Hat2 was immunoprecipitated as described in section 2.4.10. Two hundred OD600 
equivalents of wild type and Hat2-deficient cells were broken with glass beads in the 
FastPrep. Protein extracts were incubated with 50µl of the Hat2-antiserum overnight. 
Antibodies and bound proteins were precipitated by binding to magnetic beads for 4 hours. 
Finally, 0.01 OD600 equivalents of the input and the supernatant after immunoprecipitation 
and half of the immunoprecipitated material were separated through a 15% SDS-PAGE gel 
and visualized by silver staining. At about 43kDa, the predicted mobility of Hat2, a protein 
band was visible which was missing in the hat2∆/∆ strain. The IP was then analyzed by 
immunoblotting. Therefore, 1 OD600 equivalent of the input and the supernatant after 
immunoprecipitation and half of the immunoprecipitated material was separated through a 
15% SDS-PAGE gel and blotted onto a nitrocellulose membrane. Hat2 was detected in the 
precipitated fraction of the wild type. Unfortunately, no Hat1 or histone H4 was detectable in 
the IP (Figure 22).  
 
Figure 22: Hat2 immunoprecipitation. Wild type and hat2∆/∆ strains were grown to an OD600 of 2, 
harvested and broken with glass beads in breaking buffer A. 50µl Hat2-antiserum was added to 
protein extracts and incubated overnight at 4°C. Antibodies were precipitated by binding to magnetic 
beads. 1 OD600 equivalent of input and supernatant after immunoprecipitation, and half of the 
immunoprecipitated material, was separated through a 15% SDS-PAGE gel and blotted onto a 
nitrocellulose membrane. Hat1 (48.4kDa), Hat2 (42.9kDa) and histone H4 (11.6kDa) were detected 
with specific antibodies. 
 
The immunoprecipitation was repeated as described above with 10µl Hat2-antiserum. This 
time 0.1 OD600 equivalents of the input and the supernatant after immunoprecipitation and 
half of the immunoprecipitated material were separated through a 12% SDS-PAGE gel and 
visualized by silver staining. Again a band corresponding to Hat2 was visible in the 
immunoprecipitated fraction of the wild type. However, in the Western blot analysis, no 
Hat1 was detectable in the IP. 
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Therefore, the immunoprecipitation was repeated with a less stringent breaking buffer 
(10mM Tris-HCl pH 8.0, 150mM NaCl, 0.1% Nonidet P40) to increase the binding of Hat1 
to Hat2. This time 3µl Hat2-antiserum were used to precipitate Hat2. Again, 0.1 OD600 
equivalents of the input and the supernatant after immunoprecipitation and half of the 
immunoprecipitated material were separated through a 12% SDS-PAGE gel and visualized 
by silver staining. Hat2 was visible in the immunoprecipitated fraction of the wild type. 
However, in the Western blot, no Hat1 was detectable in the precipitated fraction (Figure 
23). 
 
Figure 23: Hat2 immunoprecipitation. Wild type and hat2∆/∆ strains were grown to an OD600 of 2, 
harvested and broken up with glass beads in 10mM Tris-HCl pH 8.0, 150mM NaCl, 0.1% Nonidet 
P40. 3µl Hat2-antiserum was added to protein extracts and incubated overnight at 4°C. Antibodies 
were precipitated by binding to magnetic beads. For silver staining, 0.1 OD600 equivalents of input 
and supernatant after immunoprecipitation and half of the immunoprecipitated material was 
separated through a 12% SDS-PAGE gel and stained. For Western blotting, 1 OD600 equivalent of 
input and supernatant and half of the immunoprecipitated material was separated through a 12% 
SDS-PAGE gel and blotted onto a nitrocellulose membrane. Hat1 (48.4kDa) and Hat2 (42.9kDa) 
were detected with specific antibodies. 
 
Hat1-immunoprecipitation 
Hat1 was immunoprecipitated as described in section 2.4.10 using the purified Hat1-
antibodies from the 4th bleed. Two hundred OD600 equivalents of wild type and Hat1-
deficient cells were disrupted with glass beads in breaking buffer A in the FastPrep. Protein 
extracts were incubated with 25µl of the purified Hat1-antibodies overnight. Antibodies and 
bound proteins were precipitated by binding to magnetic beads. Subsequently, 0.1 OD600 
equivalents of the input and the supernatant after immunoprecipitation and half of the 
immunoprecipitated material were separated through a 12% SDS-PAGE gel. Silver staining 
revealed no bands that were only present in the immunoprecipitated fraction of the wild 
type but not in extracts from hat1∆/∆ cells. Immunoblotting of 1 OD600 equivalent of the 
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input and the supernatant after immunoprecipitation and half of the IP showed no Hat1 in 
the precipitated fraction of the wild type (Figure 24). 
 
Figure 24: Hat1 immunoprecipitation. Wild type and hat1∆/∆ strains were grown to an OD600 of 2, 
harvested and disrupted with glass beads in breaking buffer A. 25µl purified Hat1-antibodies was 
added to protein extracts and incubated overnight at 4°C. Antibodies were precipitated by binding to 
magnetic beads. 1 OD600 equivalent of input and supernatant after immunoprecipitation and half of 
the immunoprecipitated material was separated through a 12% SDS-PAGE gel and blotted onto a 
nitrocellulose membrane. Hat1 (48.4kDa) and Hat2 (42.9kDa) were detected with specific antibodies. 
 
The immunoprecipitation was repeated several times under different conditions. The buffer 
was changed to a less stringent buffer (10mM Tris-HCl pH 8.0, 150mM NaCl, 0.1% Nonidet 
P40), and the amount of antibodies used was increased to up to 100µl, but precipitating 
Hat1 remained impossible.  
To see if the Hat1-epitope recognized by the Hat1-antibodies may be hidden in its native 
conformation, SDS was added to the breaking buffer at a final concentration of 2%. Still no 
Hat1 was detected. 
The immunoprecipitation was repeated, this time coupling 100µl of purified α-Hat1-
antibodies to the beads first by incubating them with 50µl beads for 10 minutes at room 
temperature and then adding the cell extract of 200 OD600 equivalents, using 10mM Tris-
HCl pH 8.0, 100mM NaCl as breaking buffer. Hat1 was not detectable in the precipitated 
fraction. The amount of Hat1-antibody was increased to 200µl without any success of 
precipitating Hat1 (Figure 25). 
 
Results 
61 
Figure 25: Hat1 immunoprecipitation. Wild type and hat1∆/∆ strains were grown to an OD600 of 2, 
harvested and disrupted with glass beads in 10mM Tris-HCl pH 8.0, 100mM NaCl. 200µl purified 
Hat1-antibody was bound to magnetic beads which were then added to protein extracts and 
incubated overnight at 4°C. For silver staining, 0.1 OD600 equivalents of input and supernatant after 
immunoprecipitation and half of the immunoprecipitated material was separated through a 12% 
SDS-PAGE gel and stained. For Western blotting, 1 OD600 equivalent of input and supernatant and 
half of the immunoprecipitated material was separated through a 12% SDS-PAGE gel and blotted 
onto a nitrocellulose membrane. Hat1 (48,4kDa) was detected with the purified Hat1 antibodies. 
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3.2. Hat2-Tagging 
In Saccharomyces cerevisiae, Hat1 and Hat2 are mainly located in the nucleus (Poveda et 
al., 2004). The nuclear localization of ScHat1 depends on ScHat2 but localization of ScHat2 
is independent of ScHat1. In Candida albicans, GFP-tagged Hat1 localizes to the nucleus 
independently of Hat2 (Michael Tscherner, unpublished data). To investigate the 
subcellular localization of Hat2, it was epitope-tagged with a fluorescent protein. 
 
3.2.1. Hat2-YFP Tagging in WT and hat1∆/∆ Background 
The YFP coding sequence was PCR-amplified from Yep532-YFP and cloned into the 
plasmids pFA6a and pSFS3b using SmaI AscI and KpnI ApaI, respectively, giving rise to 
the plasmids pFA6a-YFP and pSFS3b-YFP. Both plasmids carry the Candida albicans 
selection marker NAT1. pSFS3b contains the flippase FLP and the corresponding flippase 
recognition targets (FRTs), which can be used to excise the selection marker after 
integration of the tagging cassette into the genome (Reuss et al., 2004). 
A Hat2-YFP tagging cassette was constructed by fusion PCR as described in section 2.3.7. 
The 3’ part of the coding region and the downstream region of HAT2 were PCR-amplified 
from genomic DNA and a fragment containing the YFP coding sequence and the marker 
was amplified from the plasmid pFA6a-YFP. However, amplifying and fusion of all three 
fragments in one PCR-reaction to obtain the tagging cassette did not work. Therefore, 
intermediate fragments were constructed: one fragment consisting of the 3’ part of the 
HAT2 coding region and YFP, the other of the YFP-marker and the downstream region of 
HAT2. These two fragments were then combined by fusion PCR (Figure 26). This cassette 
was used to insert the YFP coding sequence in frame with the coding sequence of Hat2, 
resulting in a C-terminally tagged Hat2-YFP fusion protein. After transformation by 
electroporation integration at the correct locus was verified by colony PCR. 
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Figure 26: Hat2-YFP tagging cassette generated by fusion PCR. Fragments A and C were PCR-
amplified from genomic DNA with primers 55_CA2146_FPTag and 53_HAT2-FPTag for fragment A 
and primers 35_HAT2-pFA and 33_Ca2146 for fragment C. Fragment B was PCR-amplified from 
plasmid pFA6a-YFP with primers FPoe_fwd and pFA6a-backb_rev. Fragment AB was generated by 
mixing fragment A with fragment B in one PCR reaction and amplifying with primers 
55_CA2146_FPTag and pFA6a-backb_rev. Fragment BC was generated by mixing fragment B with 
fragment C in one PCR-reaction and amplifying with primers FPoe_fwd and 33_Ca2146. The whole 
tagging cassette (fragment ABC) was generated by mixing fragment AB with fragment BC in one 
PCR-reaction and amplifying with primers 55_CA2146_FPTag and 33_Ca2146. Integration of the 
cassette at the correct genomic locus was verified with primers 5C_HAT2_FPTag and FPTag_5C at 
the 5’ side and heukan3 and 3C_Ca2146 at the 3’ side. 
 
Hat2-deficient Candida albicans cells form wrinkled colonies under yeast-promoting 
conditions, indicating constitutive filamentous growth. Moreover, cells are sensitive to 
genotoxic agents (Michael Tscherner, unpublished data). To confirm the functionality of the 
C-terminally tagged Hat2-YFP fusion protein, the tagging cassette was transformed into a 
heterozygous HAT2 knock-out strain, resulting in a HAT2-YFP/hat2∆ strain. If the tagged 
Hat2-YFP protein was not functional, the strain would show the phenotype of a hat2∆/∆ 
deletion strain. Integration of the tagging cassette at the correct locus was confirmed by 
colony PCR as described in section 2.2.5 using primer-pairs with one primer binding 
outside and one within the tagging cassette. Expression of Hat2-YFP was also checked by 
immunoblotting. In transformed strains, a signal at 69.8kDa was detected consistent with 
the expected molecular mass of Hat2-YFP. On YPD, the Hat2-YFP strain formed smooth 
colonies, indicating yeast-form growth (Figure 27 (A)). This was confirmed by inspection of 
single cells in the microscope (Figure 28). Examining its sensitivity to genotoxic agents, we 
found that it showed the same sensitivity to MMS and NQO as the wild type (Figure 27 (B)), 
demonstrating that Hat2-YFP is indeed functional. 
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Figure 27: Functionality of Hat2-YFP. (A) Wild type, hat2∆/∆ cells and Hat2-YFP expressing cells 
were plated on YPD and photographed after 3 days at 30°C. The Hat2-YFP expressing strain forms 
smooth colonies, indicating yeast-form growth. (B) To investigate sensitivity to genotoxic agents cells 
were spotted in serial dilutions (1:5) on plates containing 0.03% methyl methane sulfonate (MMS) 
and incubated at 30°C for 3 days. The Hat2-YFP strain has wild type sensitivity to MMS. 
 
To visualize the subcellular localization of Hat2-YFP, cells were stained with Hoechst33342 
and the samples were analyzed by fluorescence microscopy. Hat2-YFP was found to be 
localized mainly in the nucleus (Figure 28).  
To further characterize the localization of Hat2, we asked whether Hat2 localization 
depends on Hat1. For transformation of Hat2-YFP into a Hat1-deficient strain, another 
tagging cassette was used. The cassette was constructed as described above, except 
using the plasmid pSFS3b-YFP instead of pFA6a-YFP as a template for the YFP and 
marker fragment. This way, thanks to the flipper construct, the NAT1 marker could be 
recycled. The Hat2-YFP tagging cassette was transformed into a hat1∆/∆ hat2∆/HAT2 
strain, and the integration was confirmed by colony PCR. Again expression of Hat2-YFP 
was checked by immunoblotting. In transformed strains, a signal at 69.8kDa was detected 
consistent with the expected molecular mass of Hat2-YFP. 
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Cells were examined in the microscope to determine the localization of Hat2-YFP. 
Interestingly, in hat1∆/∆ cells the nuclear localization of Hat2-YFP was lost and the Hat2-
YFP-signal was distributed throughout the cell (Figure 28). To confirm that the loss of the 
nuclear localization was in fact due to the deletion of HAT1, HAT1 was reintegrated into its 
original locus (reintegration cassette kindly provided by Michael Tscherner). The 
reintegration of HAT1 was checked by colony PCR. Inspection of these cells in the 
microscope revealed that the nuclear localization of Hat2-YFP was fully restored by HAT1 
reintegration, confirming that in Candida albicans nuclear localization of Hat2 requires Hat1. 
 
Figure 28: Hat2-YFP localization. Cells in the logarithmic phase grown in YPD at 30°C were 
stained with Hoechst33342. Hat2-YFP is localized in the nucleus. In the hat1∆/∆ background the 
nuclear localization is lost and the signal is distributed throughout the cell. Reintegration of HAT1 
restores the nuclear localization of Hat2-YFP. 
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The Hat1/Hat2 complex is involved in DNA damage repair (Michael Tscherner, unpublished 
data). To investigate the effect of DNA-damaging agents on the Hat2-localization, the Hat2-
YFP-expressing strain was treated with MMS and stained with Hoechst33342. Samples 
were analyzed by fluorescence microscopy. In untreated cells the nuclear Hat2-YFP signal 
was relatively low. After treatment with MMS the signal intensity in the nucleus increased 
dramatically (Figure 29).  
 
Figure 29: Nuclear Hat2-YFP signal increases after MMS treatment. Cells in the logarithmic 
phase grown in YPD at 30°C were treated with 0.02% MMS for 4 hours and stained with 
Hoechst33342.  
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3.2.2. Hat2-RFP and Hat2-mCherry Tagging 
To investigate the localization of Hat1 and Hat2 in the same strain, we decided to construct 
a double-tagged strain. Using the already present Hat1-GFP and Hat2-YFP was not 
possible due to a significant spectral overlap of GFP and YFP. Therefore, we decided to 
use Hat1-GFP and attached a red fluorescent protein to Hat2.  
The DsRFP gene from the plasmid pMG2160, obtained from the FGSC (Gerami-Nejad et 
al., 2009) was PCR-amplified and cloned into plasmids pFA6a and pSFS3b using SmaI 
AscI and KpnI ApaI, respectively, giving rise to the plasmids pFA6a-RFP and pSFS3b-RFP. 
Both plasmids were sequenced to ensure the integration of the correct fragment. 
Since generating a tagging cassette with YFP by overlap PCR proved to be difficult, the 
construction of the RFP-tagging cassette was done by cloning. The downstream region of 
HAT2 was cloned into pSFS3b-RFP using SacI and NotI, resulting in the plasmid pSFS3b-
3'HAT2_RFP. Next, the 3’ coding region of HAT2 was cloned into pSFS3b-3'HAT2_RFP 
using XmaI, resulting in the plasmid pSFS3b-HAT2_RFP. This plasmid was linearized 
using PvuI and used as Hat2-RFP tagging cassette. Hat2-RFP was integrated into a 
HAT1/hat1∆ HAT2/hat2∆ strain, to check the functionality of the tagged Hat1 and Hat2 
proteins. Integration of the cassette at the correct genomic locus was checked by colony 
PCR. Expression of Hat2-RFP was confirmed by immunoblotting. Western blot analysis 
showed a protein at the expected mobility corresponding to Hat2-RFP. Cells were stained 
with Hoechst33342 and inspected in the microscope. However, no RFP-signal was 
detectable 
 
Figure 30: Expression of Hat2-RFP. 0.4 OD600 equivalents TCA-extract of the indicated strains 
were separated through a 12% SDS-PAGE gel and blotted onto a nitrocellulose membrane. Hat2-
RFP (68.6kDa) was detected with α-RFP-antibodies (1:1000). The HAT1/hat1∆ HAT2/hat2∆ strains 
(lane 1 and 4) served as negative controls, the ScHHF22-mCherry strain (lane 10) as positive control 
(38.1kDa). 
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To check the functionality to the RFP in Candida albicans, it was placed under the control 
of the ACT1 promoter. This was done by integrating the RFP coding sequence into the 
ACT1 locus. The upstream and downstream regions of ACT1 were PCR-amplified from 
genomic DNA. RFP and the selection marker were amplified from pFA6a-RFP. The three 
fragments were then combined in a fusion PCR to generate the RFP cassette. This 
cassette was transformed into the wild type strain SC5314. Integration of the cassette at 
the correct genomic locus was verified by colony PCR. Expression of RFP was confirmed 
by immunoblotting. Only a very weak signal was detected at 25kDa, which would 
correspond to the mobility of RFP. Cells were also examined in the microscope but no RFP 
signal was visible. 
The Hat2-tagging was repeated with another red fluorescent protein: mCherry. The 
mCherry gene from the plasmid pMG2254 (obtained from the FGSC (Gerami-Nejad et al., 
2009)) was PCR-amplified and cloned into plasmids pFA6a and pSFS3b using SmaI AscI 
and KpnI ApaI, respectively, giving rise to the plasmids pFA6a-mCherry and pSFS3b-
mCherry.  
The construction of the Hat2-mCherry tagging cassette was carried out as described for the 
Hat2-RFP tagging cassette. Western blot analysis of strains transformed with this cassette 
showed a protein at the expected mobility of 69.7kDa (Figure 31, lane 1, 3, 5, 6, 7 and 8), 
but no mCherry signal was detected in the microscope. 
 
Figure 31: Expression of Hat2-mCherry. 0.4 OD600 equivalents TCA-extract of the indicated strains 
were separated through a 12% SDS-PAGE gel and blotted onto a nitrocellulose membrane. Hat2-
mCherry (69.7kDa) was detected with α-Hat2-antibodies (1:4000). The hat2∆/∆ strain (lane 9) 
served as negative control, the HAT1/hat1∆ HAT2/hat2∆ strain (lane 10) as positive control (Hat2 
42.9kDa). 
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3.3. Deletion of RTT109 and ASF1 
3.3.1. Deletion of RTT109 
Deletion of RTT109 was carried out using the flipper cassette from the plasmid pSFS3b 
(Figure 32). Upstream and downstream region of the RTT109 ORF were PCR-amplified. 
The downstream region was cloned into pSFS3b behind the marker cassette using BglII 
and NotI yielding the plasmid pSFS3b-3'RTT109. The upstream region was then cloned in 
front of the marker region using KpnI and ApaI resulting in the plasmid pSFS3b-
RTT109urdr. The plasmid was linearized with PvuII and used as the deletion cassette. The 
cassette was transformed into the wild type strain SC5314 by electroporation as described 
in section 2.2.4. Integration of the knock-out cassette was confirmed by colony PCR using 
primer pairs with one primer binding outside and one within the deletion construct. The 
NAT1 marker was flipped out by incubating overnight in YP+2% maltose and selecting for 
colonies that had lost their nourseothricin resistance. The knock-out procedure was 
repeated with this strain to obtain a homozygous rtt109∆/∆ strain. As a control, RTT109 
was also reintegrated into the homozygous rtt109∆/∆ strain (Figure 33). Hence, the coding 
sequence plus the upstream and downstream region was PCR-amplified from genomic 
DNA and cloned into pSFS3b-3'RTT109 using KpnI and ApaI, resulting in the plasmid 
pSFS3b-CaRTT109-Rev. The plasmid was linearized with PvuII and used for 
transformation into the rtt109∆/∆ strain. Integration at the correct genomic locus was 
verified by colony PCR. 
 
Figure 32: Parental plasmid pSFS3b for construction of knock-out cassettes. 
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Figure 33: Flowchart of RTT109 knock-out construction. 
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Filamentous growth in Candida albicans can be induced by several stimuli, one of which is 
DNA damage. Lack of Rtt109 mediated H3K56 acetylation in S. cerevisiae leads to 
spontaneous DNA damage (Han et al., 2007). Therefore, we examined the morphology of 
cells lacking Rtt109. These cells showed a wrinkled colony morphology indicating 
filamentous growth under yeast-promoting conditions (Figure 34 (A)). This was confirmed 
by microscopic inspection of single cells, which showed elongated cell morphologies 
(Figure 34 (B)). 
 
Figure 34: Morphology of the rtt109∆/∆ strain. (A) Wild type (WT) and rtt109∆/∆ cells were plated 
on YPD and incubated at 30°C for 3 days. (B) Cells in logarithmic phase grown in YPD at 30°C. 
 
To test the sensitivity of Rtt109-deficient cells to DNA-damaging agents, cells were spotted 
onto YPD plates containing methyl methane sulfonate (MMS), ethyl methane sulfonate 
(EMS) and 4-nitroquinoline 1-oxide (NQO). The homozygous rtt109∆/∆ strain was 
hypersensitive to all three substances, whereas the heterozygous rtt109∆/RTT109 strain 
showed the same sensitivity as the wild type. Reintegration of RTT109 into the 
corresponding locus in the knock-out strain fully restored the wild type phenotype (Figure 
35). 
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Figure 35: Sensitivity of rtt109∆/∆ to DNA-damaging agents and H2O2. Cells were spotted in 
serial dilutions (1:5) on YPD plates containing 0.5% ethyl methane sulfonate (EMS), 0.03% methyl 
methane sulfonate (MMS), 4mM hydrogen peroxide (H2O2) or 0.5µM 4-nitroquinoline 1-oxide (NQO) 
and incubated at 30°C for 3 days. 
 
Furthermore, the rtt109∆/∆ strain also showed some sensitivity to hydrogen peroxide 
(H2O2), a reactive oxygen species.  
 
Next, a hat1∆/∆ rtt109∆/∆ double knock-out strain was constructed. Both alleles of HAT1 
were sequentially deleted in the homozygous rtt109∆/∆ strain using the HAT1 knock-out 
cassette (kindly provided by Michael Tscherner) using the SAT1 flipper. 
Sensitivity of the hat1∆/∆ rtt109∆/∆ double knock-out strain to MMS, NQO and H2O2 was 
tested in spot assays (Figure 36). The hat1∆/∆ strain as well as the rtt109∆/∆ strain was 
sensitive to MMS and NQO, though the rtt109∆/∆ strain had an increased sensitivity to 
MMS compared to the hat1∆/∆ strain. Cells lacking Hat1 and Rtt109, showed the same 
sensitivities to MMS as the rtt109∆/∆ strain. Hat1-deficient cells, but not Rtt109-deficient 
cells showed an increased resistance to H2O2. The hat1∆/∆ rtt109∆/∆ double knock-out 
exhibited the same hyperresistance as the hat1∆/∆ strain. 
 
Figure 36: Sensitivity of hat1∆/∆ rtt109∆/∆ to DNA-damaging agents and H2O2. Cells were 
spotted in serial dilutions (1:5) on YPD plates containing 0.005% methyl methane sulfonate (MMS), 
0.3µM 4-nitroquinoline 1-oxide (NQO) or 6mM hydrogen peroxide (H2O2) and incubated at 30°C for 2 
days. 
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3.3.2. Deletion of ASF1 
For the deletion of ASF1, we constructed a knock-out cassette following the same scheme 
as described for RTT109 in Figure 33. The flanking regions of the ASF1 coding sequence 
were cloned into pSFS3b using BglII and NotI for the downstream region (pSFS3b-3'ASF1), 
and ApaI and KpnI for the upstream region resulting in the plasmid pSFS3b-ASF1urdr. The 
plasmid was linearized with PvuII and used as knock-out cassette. The ASF1 knock-out 
cassette was transformed into the wild type strain SC5314 by electroporation. Integration at 
the correct genomic locus was verified by colony PCR. The NAT1 marker was flipped out 
by incubating cells overnight in YP+2% maltose and selecting for colonies that had lost their 
nourseothricin resistance. 
The knock-out procedure was repeated with the ASF1 knock-out cassette but no clones 
lacking both alleles of ASF1 were obtained. It seems that Asf1 is essential (Davis et al., 
2002). Therefore, we decided to put one copy of ASF1 under a repressible promoter after 
deleting the other allele. The Candida albicans MET3 promoter was chosen. This promoter 
is repressed in the presence of 2.5mM methionine and 0.5mM cysteine (Care et al., 1999). 
1.4kb of the MET3 promoter and the ASF1-ORF were PCR-amplified. A PMET3-ASF1 
fragment was created by fusion PCR using the two outer primers MET3-P_SmaI_fwd and 
ASF1_AscI_rev. This fragment was cloned into pFA6a with SmaI and AscI resulting in the 
plasmid pFA6a-MET3-P_ASF1. The plasmid was linearized with BsaBI and AscI, thereby 
removing the last 215bp of the ASF1 coding sequence. This cassette was then transformed 
into the heterozygous asf1∆/ASF1 strain. Integration into the ASF1 CDS would disrupt the 
remaining wild type allele and place ASF1 under the control of the MET3 promoter. To 
ensure that no methionine or cysteine were present in the medium, which would repress 
the MET3 promoter, minimal media was used in the transformation protocol. Since 
ammonium sulfate impairs the function of nourseothricin, 1g/l glutamic acid was used as 
nitrogen source instead (Tong and Boone, 2006). However, no positive clones able to grow 
in the absence but not in the presence of methionine and cysteine were obtained.  
In S. cerevisiae, the C-terminally region of Asf1 is not required for functionality (Umehara et 
al., 2002). Thus, it is possible that the truncated version, which remains in the genome after 
using the approach described above, is still functional. Therefore, the PMET3-ASF1 fragment 
was amplified using a primer that was binding in the middle of ASF1 CDS (MET3-
P_SmaI_fwd and ASF1_2_AscI_rev) giving rise to a fragment consisting of the MET-
promoter and only the first 299bp of ASF1. This fragment was cloned into pFA6a using 
SmaI and AscI resulting in the plasmid pFA6a-MET3-P_ASF1_2. The cassette was then 
PCR-amplified with ASF1_int_fwd and ASF1_int_rev. This cassette was transformed into 
the heterozygous asf1∆/ASF1 strain. No positive clones able to grow in the absence but not 
in the presence of methionine and cysteine were obtained. 
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Since we were unable to obtain positive clones this way, we decided to replace the ASF1-
promoter with the MET3-promoter. To do this a region upstream of the ASF1-promoter 
(ur_ASF1_fwd and ur_ASF1_rev), the MET3-promoter (MET3-P_KpnI_fwd and MET3-
P_oe_rev) and full length ASF1 (ASF1_oe_fwd and 33_ASF1_NotIApaI_rev) was PCR-
amplified from genomic DNA. The PMET3-ASF1 fragment was created by fusion PCR using 
the two outer primers MET3-P_KpnI_fwd and 33_ASF1_NotIApaI_rev. This fragment was 
then cloned into pSFS3b-3'ASF1 with KpnI and ApaI resulting in the plasmid pSFS3b-
MET3P-ASF1-drASF1. The upstream ASF1 region was then cloned into this plasmid with 
KpnI giving rise to the plasmid pSFS3b-urASF1-MET3P-ASF1-drASF1. This plasmid was 
linearized with PvuII and transformed into the asf1∆/ASF1 strain. Integration at the correct 
genomic locus was verified by colony PCR. In all transformants, the cassette failed to 
integrate at the ASF1 wild type allele, but integrated at the asf1∆ knock-out allele instead. 
The NAT1 marker was flipped out by incubating cells overnight in YP+2% maltose and 
selecting colonies that had lost their nourseothricin resistance. The strain was then 
transformed by electroporation with the ASF1 knock-out cassette to delete the remaining 
wild type allele. However, no positive clones, which had integrated the cassette at the 
correct locus, were obtained. 
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3.4. Histone H4 Mutants 
3.4.1. Deletion of HHF1 and HHF22 
The Candida albicans genome contains two genes encoding histone H4: HHF1 
(orf19.1059) and HHF22 (orf19.1854) (Zacchi et al., 2010). To introduce mutations 
mimicking the acetylated or deacetylated state of lysine 5 and 12, first the number of wild 
type histone H4 copies was reduced by sequentially deleting 2 copies of HHF1 and one 
copy of HHF22. First, a knock-out cassette for HHF1 was constructed. The upstream and 
downstream region of HHF1 were PCR-amplified from genomic DNA and cloned into 
pSFS3b using BglII and NotI for the downstream region (pSFS3b-3'HHF1) and ApaI and 
KpnI for the upstream region, resulting in the plasmid pSFS3b-HHF1urdr. The plasmid was 
linearized with PvuII and transformed by electroporation into the wild type strain SC5314. 
Integration at the correct genomic locus was verified by colony PCR. The NAT1 marker was 
flipped out by incubating cells overnight in YP+2% maltose and selecting colonies that had 
lost their nourseothricin resistance. To delete the second allele of HHF1, the knock-out 
procedure was repeated as described above. For deleting HHF22, a HHF22 knock-out 
cassette was constructed. The flanking regions of HHF22 were PCR-amplified from 
genomic DNA and cloned into pSFS3b using BglII and NotI for the downstream region 
(pSFS3b-3'HHF22) and ApaI and KpnI for the upstream region, resulting in the plasmid 
pSFS3b-HHF22urdr. The plasmid was linearized with PvuII and transformed by 
electroporation into the homozygous hhf1∆/∆ strain. Integration at the correct genomic 
locus was verified by colony PCR. The NAT1 marker was flipped out by incubating cells 
overnight in YP+2% maltose and selecting colonies that had lost their nourseothricin 
resistance. 
Deletion of HHF1 and HHF22 was verified by Southern blotting. Genomic DNA was isolated 
from all strains as described in section 2.2.3. For the isolation 5ml overnight culture was 
harvested, resuspended in Yeast Lysis Buffer and PCI (phenol-chlorophorm-isoamyl 
alcohol) and glass beads were added. Cells were broken up in the FastPrep and TE was 
added. RNA was digested with RNase A. DNA was precipitated and resuspended in 50µl 
dH2O. For HHF1, 25µg genomic DNA was digested with HindIII. For HHF22, 40µg genomic 
DNA was digested with BglII. DNA was separated in an agarose gel and blotted onto a 
nylon membrane. Fragments containing HHF1 or HHF22 were detected with a digoxigenin 
labeled probe and an anti-digoxigenin antibody. All strains showed bands at the expected 
sizes. 
Since it is known that low dosage of histone H4 can lead to chromosome duplication 
(Zacchi et al., 2010), the histone H4 copy number was checked by quantitative PCR as 
described in section 2.3.9. For each reaction, 7.5ng genomic DNA was used. RIP1 and 
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ECE1 were chosen as reference genes. Copy number was calculated relative to the wild 
type which harbors 4 copies of histone H4. All knock-out strains had the expected copy 
number of histone H4 (Figure 37). 
 
Figure 37: Quantitative PCR showing histone H4 copy number. qPCR was performed with 7.5ng 
genomic DNA per reaction and RIP1 and ECE1 as reference genes. Signals were normalized to the 
mean of the reference genes and to the WT signal. 
 
Next the sensitivity of the histone H4 knock-out strains to Caspofungin, methyl methane 
sulfonate (MMS), hydrogen peroxide (H2O2), Itraconazole and Voriconazole was tested 
(Figure 38). Knock-out strains with one or two copies of histone H4 deleted behaved as the 
wild type. However, the knock-out strain harboring only copy left showed increased 
sensitivity to Caspofungin. Notably, this could be rescued by addition of vitamin C. It was 
also sensitive to MMS, similar to the hat1∆/∆ strain. Another similarity was that both strains 
showed an increased resistance to H2O2. Resistance to Itraconazole and Voriconazole was 
slightly elevated in the one histone H4 copy strain compared to the wildtype, but not as 
pronounced as in the hat1∆/∆ strain (Figure 38). 
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Figure 38: Sensitivity of histone H4 knock-out strains. Cells were spotted in serial dilutions (1:5) 
on YPD plates containing 0.03µg/ml Caspofungin, 0.03µg/ml Caspofungin and 25mM vitamin C, 
0.03% methyl methane sulfonate (MMS), 6mM hydrogen peroxide (H2O2) or on SC-plates containing 
500ng/ml Itraconazole or 500ng/ml Voriconazole and incubated at 30°C for 3 days. 
 
The next step was to integrate a mutated version of HHF1 into the HHF1 locus. First, the 
coding sequence of HHF1 was PCR-amplified (55_CaHHF1 and 33_CaHHF1) and cloned 
into pSFS3b-3'HHF1 using PvuI and ApaI giving rise to the plasmid pSFS3b-CaHHF1-Rev. 
Lysine 5 and 12 were mutated to glutamine to mimic the acetylated state, and to arginine to 
mimic the unacetylated state, as described in section 2.3.8. Therefore, primers with one 
point mutation were designed changing lysine to glutamine or arginine. pSFS3b-CaHHF1-
Rev was PCR-amplified using these primers (HHF1 K12Q_fwd + HHF1 K12Q_rev, HHF1 
K12R_fwd + HHF1 K12R_rev). After the amplification, the template plasmid pSFS3b-
CaHHF1-Rev was digested with DpnI which cuts only methylated DNA, leaving behind the 
PCR-amplified and therefore unmethylated mutated version of the plasmid. The resulting 
plasmids were named pSFS3b-CaHHF1 K12Q and pSFS3b-CaHHF1 K12R and 
transformed into competent DH5α cells. To ensure the correct mutations were present in all 
plasmids, sequencing was carried out. The plasmids were linearized with PvuII and 
transformed into the histone H4 knock-out strain with only one wild type histone H4 copy 
left. As a control the non-mutagenized HHF1 was reintegrated as well. 
It has already been shown that altering the histone H4 dosage in Candida albicans leads to 
a growth defect (Zacchi et al., 2010). Therefore, a growth curve was taken for all of the 
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histone H4 knock-out strains (Figure 39). Deletion of one or two copies of histone H4 did 
not affect the growth rate. Both strains grew at about the same rate as the wild type. 
However, the knock-out strain with only one histone H4 copy left grew considerably slower 
than the others. Unfortunately, reintegration of HHF1 failed to restore the phenotype of the 
strain harboring two histone H4 copies. All strains with a reintegrated copy of HHF1 with or 
without mutation of lysine 12 grew at the same rate as the one copy strain. It is possible 
that this strain acquired some mutation during the transformation procedure. Therefore, the 
construction of a one-copy strain was repeated.  
 
Figure 39: Growth of histone H4 mutant strains. Overnight cultures were diluted to OD600 0.05 
and grown in YPD at 30°C. OD600 was measured at the indicated time points. 
 
For the previous knock-outs, only HHF1 and HHF22 were deleted. This changes the 
histone H3 / histone H4 ratio which may have potentially harmful effects (Castillo et al., 
2007; Clark-Adams et al., 1988). To reduce these effects, a knock-out cassette that would 
delete HHF22 and HHT2, which encodes histone H3, was constructed (Figure 40).  
 
Figure 40: HHT2 and HHF22 locus. 
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The upstream region of HHT2 was PCR-amplified from genomic DNA and cloned into 
pSFS3b-3'HHF22 with KpnI and ApaI giving rise to pSFS3b-5'HHT2-3'HHF22. The plasmid 
was linearized with PvuII and transformed into a strain lacking one copy of HHF1. 
Integration at the correct genomic locus was verified by colony PCR. Recombination was 
induced by incubation in YP + 2% maltose overnight. Colonies that had lost their 
nourseothricin resistance were selected and the transformation procedure was repeated. 
Several clones with integration into the correct locus were obtained. To check the histone 
H4 copy number, quantitative PCR was performed on genomic DNA isolated from all 
strains. About 7.5ng DNA was used for each reaction. RIP1 was chosen as a reference 
gene. Copy number was calculated relative to the wild type, which has 4 copies of histone 
H4. Even though colony PCR indicated integration of the knock-out cassette into the right 
locus, leaving only one histone H4 copy, qPCR indicated that in all tested strains there 
were still 2 remaining copies of histone H4 (Figure 41). While the transformation was 
repeated several times, a strain with only one copy of HHF1 and no copy of HHF22 left was 
not obtained.  
 
Figure 41: Histone H4 copy number of HHT2-HHF22 knock-outs. qPCR was performed with 
7.5ng genomic DNA per reaction and RIP1 as reference gene. Signals were normalized to the 
reference gene and to the WT signal. 
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3.4.2. Mimicking Histone H4 K5 and K12 Acetylation in a hat1∆/∆ 
Background 
Hat1-deficient cells show elongated cell morphologies and are hypersensitive to genotoxic 
agents (Michael Tscherner, unpublished data). Since Hat1 acetylates histone H4K5 and 
H4K12, we wanted to see if mutating these residues to glutamate mimicking the acetylated 
state can reverse the phenotype.  
First, one copy of HHF1 was deleted in a hat1∆/∆ strain using the knock-out cassette 
described above (linearized pSFS3b-HHF1urdr). Deletion of HHF1 was verified by colony 
PCR. The NAT1 marker was flipped out by incubating cells overnight in YP+2% maltose 
and selecting colonies that had lost their nourseothricin resistance. Linearized pSFS3b-
CaHHF1 K12Q was transformed into this strain by electroporation to introduce the HHF1 
variant carrying the K12Q mutation. As a control, the wild type HHF1 was reintegrated as 
well. Integration at the correct genomic locus was verified by colony PCR. To ensure the 
strain was carrying the mutation, HHF1 was PCR-amplified and sequenced.  
Colonies and cellular morphologies of the H4K12Q strain were inspected (Figure 42). 
Colonies showed a wrinkled morphology indicating filamentous growth. This was confirmed 
by inspection of single cells. Integration of one K12Q mutated version of HHF1 did not 
change the phenotype of the hat1∆/∆ strain.  
 
Figure 42: Morphology of hat1∆/∆ strains with H4K12Q. (A) Cells were plated on YPD and 
incubated at 30°C for 3 days. (B) Cells in logarithmic phase grown in YPD at 30°C. 
 
To see if the H4K12Q mutation had any effect on the sensitivity to genotoxic agents, the 
strains were spotted onto MMS-containing YPD plates. The HHF1 K12Q strain showed the 
same sensitivity to MMS as the hat1∆/∆ background strain (data not shown). 
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Since Hat1 can also acetylate H4K5, primers with one point mutation changing lysine 5 to 
glutamine were designed. pSFS3b-CaHHF1-Rev and pSFS3b-CaHHF1 K12Q were PCR-
amplified using these primers (HHF1 K5Q_fwd + HHF1 K5Q_rev). After the PCR, the 
parental plasmid was digested with DpnI. The plasmids were then transformed into 
competent DH5α cells. The resulting plasmids were named pSFS3b-CaHHF1 K5Q and 
pSFS3b-CaHHF1 K5Q K12Q and were sequenced to ensure they were carrying the correct 
mutations. The plasmids were linearized with PvuII and transformed by electroporation into 
the hat1∆/∆ hhf1∆/HHF1 strain. Integration at the correct genomic locus was verified by 
colony PCR. The cassette did not integrate at the knock-out allele but instead, replaced the 
wild type allele. Since it was planed to reduce the number of wild type H4 copies anyway, 
these strains were used for further experiments. To ensure the strains were carrying the 
mutations, HHF1 was PCR-amplified and sequenced.  
Colony and cell morphologies of the H4K5QK12Q strains were further investigated (Figure 
43). The wrinkled colony morphology indicated filamentous growth. This was confirmed by 
inspection of single cells. Having one mutated histone H4 copy did not change the 
phenotype when compared to the hat1∆/∆ background strain. 
 
Figure 43: Morphology of hat1∆/∆ strains with mutated H4. (A) Cells were plated on YPD and 
incubated at 30°C for 3 days. (B) Cells in logarithmic phase grown in YPD at 30°C. 
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To see if mimicking histone H4 K5 or K12 acetylation has any effect on sensitivity to 
genotoxic agents, the strains were spotted on MMS-containing YPD plates. All strains 
showed the same sensitivities to MMS as the hat1∆/∆ background strain (Figure 44). 
 
Figure 44: Sensitivity of hat1∆/∆ strains with mutated H4 to MMS. Cells were spotted in serial 
dilutions (1:5) on YPD plates containing 0.02% or 0.03% methyl methane sulfonate (MMS) and 
incubated at 30°C for 3 days. 
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4. Discussion 
4.1. α-Hat1 and α-Hat2 Antibodies 
 
Polyclonal antibodies against CaHat1 and CaHat2 were raised to be used in 
immunoblotting and immunoprecipitation experiments. Functional antibodies against both 
proteins could be obtained. However, only the α-Hat2 antibodies could be used 
successfully to precipitate their target protein in immunoprecipitation experiments. 
 
Antibodies can be a useful tool in the characterization of protein function. They allow for 
determination of protein levels via immunoblotting or can be used in immunoprecipitation 
experiments to identify binding partners. 
To raise antibodies against CaHat1 and CaHat2, the N-terminal regions of these proteins 
were expressed as GST-fusion proteins and used as antigen for immunization of rabbits. 
Unfortunately, both initial GST-fusion proteins were insoluble. Therefore, we fused other 
antigenic regions consisting of the C-terminal parts of Hat1 and Hat2 to GST. Since these 
fusion proteins were soluble, the new antigens were then purified and used to immunize 
rabbits.  
The antibodies raised against Hat2 work very well and can be used without further 
purification in dilutions up to 1:4000 in Western blot analysis. The Hat1 antiserum 
recognizes Hat1 as well as another protein of similar mobility as Hat1. To obtain specific α-
Hat1 antibodies, the purification of the antiserum became necessary. Affinity purification 
was first tested using the 4th bleed. Pure α-Hat1 antibodies were obtained. Since the 4th 
bleed was only a test bleed during the immunization, only a limited amount of antiserum 
was available for purification. Therefore, the 6th bleed, of which larger amounts of antiserum 
were present, was used for purification. However, even though functional Hat1-antibodies 
were present in the 6th bleed, the affinity purification failed to yield pure α-Hat1 antibodies. 
Even after an additional purification step of IgG precipitation, no pure α-Hat1 antibodies 
were obtained. It may be that the cross-reacting protein of the same mass as Hat1 is 
recognized by IgG antibodies, and was therefore not removed during the IgG purification. 
Thus, the affinity purification was successful for the 4th bleed but not for the 6th bleed, most 
likely because the affinity of the cross-reacting antibody increased between the 4th and 6th 
bleed and could therefore no longer be removed during the purification steps.  
 
The interaction of Hat1 and Hat2 was previously demonstrated by immunoprecipitation 
using tagged versions of the proteins (Michael Tscherner, unpublished data). Notably, 
these results were not reproduced using the polyclonal α-Hat1 and α-Hat2 antibodies. 
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Immunoprecipitation of Hat2 was successful, but Hat1 was not coprecipitating. One reason 
why Hat1 could not be coprecipitated with Hat2, may be that the epitope recognized by the 
α-Hat2 antibodies lies within the region that binds to Hat1. In this scenario, antibody binding 
would block the interaction of Hat1 with Hat2 and therefore prevent coprecipitation.  
Unfortunately, the immunoprecipitation of Hat1 did not work. Even using very low 
stringency conditions Hat1 failed to precipitate. The antibodies work fine in Western blot 
analysis but are not useful in immunoprecipitation experiments. Thus, it is possible that the 
affinity of the antibodies is too low to perform immunoprecipitations or that the antibodies 
lost their functionality during the purification procedure. Furthermore, since the antibodies 
work fine in Western blot experiments but are unable to precipitate the native protein, the 
epitope might not be accessible in the extracts with native Hat1.  
 
4.2. Intracellular Localization of Hat2 
 
Hat1 is classified as type B histone acetyltransferase, which is defined as a cytoplasmic 
enzyme acetylating free but not nucleosomal histones. Thus, one would expect to find the 
Hat1/Hat2 complex primarily in the cytoplasm. However, the Hat1/Hat2 complex has been 
detected in the nucleus in several species (Imhof and Wolffe, 1999; Lusser et al., 1999; 
Poveda et al., 2004; Verreault et al., 1998). In Saccharomyces cerevisiae, the nuclear 
localization of Hat1 depends on Hat2 but the localization of Hat2 is independent of Hat1 
(Poveda et al., 2004). Interestingly, in Candida albicans this scenario is reversed. While 
Hat1 is localized in the nucleus independently of the presence of Hat2 (Michael Tscherner, 
unpublished data), Hat2 requires Hat1 for its nuclear localization.  
The Hat1/Hat2 complex is involved in DNA damage repair, as cells lacking either one of the 
components are hypersensitive to DNA-damaging agents (Michael Tscherner, unpublished 
data). We used our Hat2-YFP tagged strain to investigate the localization of Hat2 after 
inducing DNA-damage. In cells treated with the DNA-alkylating agent methyl methane 
sulfonate (MMS), the intensity of the nuclear Hat2-YFP signal was dramatically increased, 
mirroring the results obtained with a Hat1-GFP strain (Michael Tscherner, unpublished 
data). It is, however, not clear how this is achieved, since mRNA levels of HAT1 and HAT2 
after MMS treatment remain unchanged (Michael Tscherner, unpublished data). It is 
possible that cytoplasmatic Hat1/Hat2, previously dispersed throughout the cell, is imported 
into the nucleus, becoming more concentrated and therefore detectable by microscopy. 
However, it is questionable if an increase of this magnitude could be caused solely by this 
mechanism, since no Hat2-YFP is detectable by microscopy in the cytoplasm. Another way 
of increasing the amount of Hat2-YFP, even though not as quickly, could be increased 
translation of its mRNA. 
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To investigate Hat1 and Hat2 localization within a single cell it would have been useful to 
construct a strain in which both proteins are labeled with different fluorescent proteins. 
Unfortunately, I was not able to tag Hat2 with a red fluorescent protein. Even though a 
protein of the expected molecular mass of Hat2-RFP could be detected by Western 
blotting, RFP signals were not detectable when cells were examined in the fluorescence 
microscope. The same result was obtained with another RFP variant, mCherry. It is 
possible that in both cases signals were too weak to be detectable. Another explanation 
would be that the fluorescent proteins were not folded correctly in the Hat2-RFP fusion 
protein and therefore did not fluoresce. Thus, the functionality of RFP in Candida albicans 
was tested by transforming cells with the RFP coding sequence under a constitutive active 
promoter. The expression level of RFP was very low and no signal could be detected in the 
fluorescence microscope. It seems that the RFP is not functional in Candida albicans.  
 
4.3. Histone Acetyltransferase Rtt109 and Chaperone Asf1 
 
Rtt109 is the only histone acetyltransferase responsible for histone H3K56 acetylation, a 
modification that is important for DNA damage repair in Saccharomyces cerevisiae 
(Fillingham et al., 2008). Deletion of RTT109 in Candida albicans leads to constitutive 
filamentous growth, probably induced by impaired DNA damage repair due to the lack of 
H3K56ac. Furthermore, the rtt109∆/∆ strain is hypersensitive to DNA-damaging agents. 
Cells lacking the histone acetyltransferase Hat1 are also sensitive to these substances, 
albeit to a different extent. Sensitivity to the DNA-alkylating agent MMS is strongly 
increased in the rtt109∆/∆ strain compared to the hat1∆/∆ strain, indicating that acetylation 
of histone H3 by Rtt109 is more important for DNA damage repair after double strand 
breaks than histone H4 acetylation by Hat1. The hat1∆/∆ rtt109∆/∆ double knock-out 
shows similar sensitivities to MMS as the rtt109∆/∆ single knock-out.  
Sensitivity to NQO, which typically induces DNA lesions corrected by nucleotide excision 
repair, is about the same in the hat1∆/∆ strain and the rtt109∆/∆ strain. By contrast, the 
hat1∆/∆ rtt109∆/∆ double knock-out seems to be more sensitive to NQO. Thus, both 
proteins may contribute to the repair of these lesions in parallel pathways. 
During the course of this work, two publications appeared, describing the phenotype of 
rtt109 deletion in Candida albicans (Lopes da Rosa et al., 2010; Wurtele et al., 2010). The 
published data were consistent with our results concerning the filamentation phenotype and 
DNA damage sensitivity. Furthermore, it was shown that Rtt109 is indeed responsible for 
H3K56 acetylation in Candida albicans. In addition, cells lacking Rtt109 show attenuated 
virulence in a mouse model of systemic infection (Lopes da Rosa et al., 2010; Wurtele et 
al., 2010). 
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Interestingly, the hat1∆/∆ strain exhibits increased resistance to H2O2, whereas the 
rtt109∆/∆ strain remains sensitive. In cells lacking Hat1, oxidative stress response genes 
such as CAT1 are already upregulated, even in the absence of reactive oxygen species 
(ROS) (Michael Tscherner, unpublished data), explaining why these cells are able to 
detoxify high concentrations of H2O2. The hat1∆/∆ rtt109∆/∆ double knock-out strain 
behaves like the hat1∆/∆ single knock-out strain, since it shows the same increase in H2O2 
resistance. Thus, Hat1 may be in addition involved in a pathway other than the DNA 
damage repair-associated histone deposition. The latter influences the expression of 
oxidative stress response genes and is completely independent of Rtt109. 
 
Asf1 is a histone chaperone interacting with Rtt109. Interestingly, Asf1 is required for the 
acetylation of H3K56 by Rtt109 in Saccharomyces cerevisiae (Fillingham et al., 2008). In a 
Candida albicans insertional mutagenesis screen, ASF1 was one of several genes from 
which no homozygous mutants could be obtained, indicating that it may be essential (Davis 
et al., 2002). We tried to delete ASF1 in a targeted approach, but were also unable to 
construct a homozygous asf1∆/∆ strain. Therefore, ASF1 was placed under a conditional 
promoter. Unfortunately, deletion of the remaining ASF1 wild type allele was not possible. It 
is possible that the endogenous ASF1 promoter is stronger than the inducible MET3 
promoter used here. Therefore, cells with only one copy of ASF1 under the control of the 
MET3 promoter might not express sufficient amounts of Asf1 to be viable. 
 
4.4. Mimicking Histone H4 Acetylation 
 
As in all other organisms investigated so far, the Candida albicans histone 
acetyltransferase Hat1 acetylates histone H4 on positions 5 and 12 (Michael Tscherner, 
unpublished data). In fact, the Candida albicans histone H4 N-terminus contains two 
additional amino acids when compared to Saccharomyces cerevisiae. Therefore, the lysine 
residues 5 and 12 are actually at position 7 and 14, respectively. Nevertheless, since these 
residues are based on the sequence homology equivalent to K5 and K12 in 
Saccharomyces cerevisiae and many other organisms the same description was used in 
this thesis for Candida albicans as well. To study the effect of lysine 5 and 12 acetylation on 
chromatin assembly and DNA damage repair, these residues were mutated to mimic the 
acetylated or unacetylated state. To reduce the number of wild type histone H4, 3 out of the 
4 histone H4 genes were deleted before introducing a mutated histone H4 variant gene. As 
already published (Zacchi et al., 2010), the strain harboring only one copy of histone H4 
grows considerably slower than strains with 2, 3 or 4 copies. Furthermore, it shows 
increased sensitivity to Caspofungin and MMS, similar to the hat1∆/∆ strain. The single 
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copy H4 strain exhibits additional similarities to the hat1∆/∆ strain. For example, both 
strains are more resistant to H2O2. As mentioned before, oxidative stress response genes 
are upregulated in the hat1∆/∆ strain. Whether H2O2 resistance in the single copy H4 strain 
is conferred by the same mechanism has to be determined. Furthermore, both strains show 
increased tolerance to Itraconazole and Voriconazole. However, resistance in the single 
copy H4 strain is only slightly elevated, whereas it is considerably stronger in the hat1∆/∆ 
strain. The elevated resistance in this strain may be due to upregulation of several 
transporters, including the Mdr1 permease (Michael Tscherner, unpublished data). 
Possibly, a similar mechanism is active in the single copy H4 strain. 
Unfortunately, the genomic reintegration of one histone H4 gene into the single copy H4 
strain failed to restore the phenotype of the dual copy H4 strain concerning its growth 
defect. It is possible that the strain acquired some additional mutations during the 
transformation procedure. Another explanation could be that a low histone density due to 
the low histone dosage induces epigenetic changes that would not revert by reintegration of 
one histone H4 gene. 
To rule out that additional mutations were causing the problems, the construction of the 
single copy strain was repeated. This time one copy of histone H4 and one copy of histone 
H3 were deleted simultaneously to avoid dramatic changes in the histone H3 / H4 ratio. A 
strain with only two histone H4 copies was constructed this way without any problems. 
However, deletion of the third histone H4 copy failed. Even though colony PCR suggested 
positive clones, all tested strains had 2 copies of histone H4. Notably, alterations in histone 
dosage can lead to segmental or whole chromosomal trisomies (Zacchi et al., 2010), which 
would explain why, even though colony PCR verified integration at the correct genomic 
locus, quantitative PCR indicated two remaining copies of histone H4. 
 
Since Hat1 mediates histone H4K5 and H4K12 acetylation, we wanted to see if mimicking 
the acetylated state of these residues can rescue the phenotypes of a hat1∆/∆ strain. Thus, 
mutated variants of histone H4 were introduced into the hat1∆/∆ strain. Unfortunately, 
strains carrying HHF1 K5Q, K12Q or K5Q K12Q show no differences when compared to 
the hat1∆/∆ background strain with respects to cell morphology. All strains exhibit 
filamentous growth. Furthermore, sensitivity to MMS is not influenced by any of the tested 
histone H4 mutations. In these strains, one mutated and two wild type histone H4 versions 
are present. Thus, only one out of three histone H4 copies carrying the mutation is not 
enough to reverse the hat1∆/∆ phenotype. Thus, further reducing the histone H4 copy 
number in these strains may help to rescue the hat1∆/∆ phenotype. Furthermore, the 
acetylation of histone H4 by Hat1 may only be a transient modification, which is rapidly 
removed after incorporation into chromatin. The mutation introduced to mimic acetylation is 
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a permanent mark that cannot be removed and might therefore cause additional pleiotropic 
effects. Furthermore, the absence of acetylated H4K5 and K12 may not be the only 
explanation for the defects observed in the hat1∆/∆ strain. Hat1 may play a role in another 
pathway that cannot be rescued by mimicking acetylation of histone H4 lysine residues. 
 
In summary, during this thesis antibodies against both Hat and Hat2 were raised 
successfully and the nuclear localization of Hat2 was elucidated by epitope tagging. 
Furthermore, the function of the histone acetyltransferase Rtt109 was investigated and it 
was shown that cells lacking Rtt109 exhibit a similar phenotype to those lacking Hat1. 
Additionally, to further investigate the role of histone acetylation by Hat1, strains mimicking 
these modifications were constructed. However, they could not rescue the hat1∆/∆ 
phenotype. 
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